| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | GTPase activator activity | TSC2 ARHGAP30 TBC1D10C RABGAP1L TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D10B ARAP3 | 6.49e-08 | 279 | 244 | 17 | GO:0005096 |
| GeneOntologyMolecularFunction | protein kinase binding | MAP3K12 SPDYE11 SPDYE15 TELO2 SYN1 TJP2 MAP3K11 SPDYE21 ULK1 SPDYE5 SPDYE2B SPDYE14 SPDYE17 SPDYE10 TNS2 ARTN SPDYE18 SPDYE12 ZFP36 FAM83H MLXIPL LDB3 SPDYE3 SPDYE2 DACT3 SPDYE8 SMO IRS2 BRSK1 SPDYE6 | 3.32e-07 | 873 | 244 | 30 | GO:0019901 |
| GeneOntologyMolecularFunction | acetylcholine receptor regulator activity | 7.47e-07 | 27 | 244 | 6 | GO:0030548 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor regulator activity | 9.42e-07 | 28 | 244 | 6 | GO:0099602 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | PSD TSC2 ARHGAP30 TBC1D10C DENND4B RABGAP1L TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D10B ARAP3 TNK2 PSD4 | 1.22e-06 | 507 | 244 | 21 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | PSD TSC2 ARHGAP30 TBC1D10C DENND4B RABGAP1L TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D10B ARAP3 TNK2 PSD4 | 1.22e-06 | 507 | 244 | 21 | GO:0030695 |
| GeneOntologyMolecularFunction | histone H3K4 monomethyltransferase activity | 1.47e-06 | 8 | 244 | 4 | GO:0140945 | |
| GeneOntologyMolecularFunction | kinase binding | MAP3K12 SPDYE11 SPDYE15 TELO2 SYN1 TJP2 MAP3K11 SPDYE21 ULK1 SPDYE5 SPDYE2B SPDYE14 SPDYE17 SPDYE10 TNS2 ARTN SPDYE18 SPDYE12 ZFP36 FAM83H MLXIPL LDB3 SPDYE3 SPDYE2 DACT3 SPDYE8 SMO IRS2 BRSK1 SPDYE6 | 2.85e-06 | 969 | 244 | 30 | GO:0019900 |
| GeneOntologyMolecularFunction | histone H3K4 trimethyltransferase activity | 4.31e-06 | 10 | 244 | 4 | GO:0140999 | |
| GeneOntologyMolecularFunction | histone H3K4 methyltransferase activity | 9.04e-05 | 20 | 244 | 4 | GO:0042800 | |
| GeneOntologyMolecularFunction | enzyme activator activity | TSC2 ARHGAP30 MAP3K12 TBC1D10C RABGAP1L TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D10B ARAP3 AJUBA | 4.73e-04 | 656 | 244 | 19 | GO:0008047 |
| GeneOntologyBiologicalProcess | activation of GTPase activity | TBC1D10C TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D10B | 3.13e-10 | 109 | 233 | 13 | GO:0090630 |
| GeneOntologyBiologicalProcess | positive regulation of cyclin-dependent protein kinase activity | 2.08e-08 | 28 | 233 | 7 | GO:1904031 | |
| GeneOntologyBiologicalProcess | positive regulation of GTPase activity | TSC2 TBC1D10C TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D10B ARAP3 | 1.28e-07 | 244 | 233 | 15 | GO:0043547 |
| GeneOntologyBiologicalProcess | positive regulation of cyclin-dependent protein serine/threonine kinase activity | 2.88e-07 | 25 | 233 | 6 | GO:0045737 | |
| GeneOntologyBiologicalProcess | regulation of GTPase activity | TSC2 TBC1D10C RABGAP1L TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D10B ARAP3 AJUBA | 2.90e-07 | 335 | 233 | 17 | GO:0043087 |
| GeneOntologyCellularComponent | histone methyltransferase complex | 2.21e-05 | 75 | 236 | 7 | GO:0035097 | |
| GeneOntologyCellularComponent | presynaptic active zone | 2.05e-04 | 141 | 236 | 8 | GO:0048786 | |
| GeneOntologyCellularComponent | methyltransferase complex | 2.27e-04 | 108 | 236 | 7 | GO:0034708 | |
| Domain | TBC | TBC1D10C RABGAP1L TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D10B | 2.12e-14 | 49 | 232 | 13 | SM00164 |
| Domain | RabGAP-TBC | TBC1D10C RABGAP1L TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D10B | 6.49e-14 | 53 | 232 | 13 | PF00566 |
| Domain | Rab-GTPase-TBC_dom | TBC1D10C RABGAP1L TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D10B | 1.09e-13 | 55 | 232 | 13 | IPR000195 |
| Domain | TBC_RABGAP | TBC1D10C RABGAP1L TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D10B | 1.09e-13 | 55 | 232 | 13 | PS50086 |
| Domain | Spy1 | 1.51e-09 | 11 | 232 | 6 | PF11357 | |
| Domain | Speedy | 1.51e-09 | 11 | 232 | 6 | IPR020984 | |
| Domain | AT_hook | 1.83e-05 | 27 | 232 | 5 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 1.83e-05 | 27 | 232 | 5 | IPR017956 | |
| Domain | FYrich_C | 1.86e-05 | 5 | 232 | 3 | IPR003889 | |
| Domain | FYrich_N | 1.86e-05 | 5 | 232 | 3 | IPR003888 | |
| Domain | FYRC | 1.86e-05 | 5 | 232 | 3 | SM00542 | |
| Domain | FYRN | 1.86e-05 | 5 | 232 | 3 | SM00541 | |
| Domain | FYRN | 1.86e-05 | 5 | 232 | 3 | PF05964 | |
| Domain | FYRC | 1.86e-05 | 5 | 232 | 3 | PF05965 | |
| Domain | FYRC | 1.86e-05 | 5 | 232 | 3 | PS51543 | |
| Domain | FYRN | 1.86e-05 | 5 | 232 | 3 | PS51542 | |
| Domain | Post-SET_dom | 3.75e-05 | 16 | 232 | 4 | IPR003616 | |
| Domain | PostSET | 3.75e-05 | 16 | 232 | 4 | SM00508 | |
| Domain | POST_SET | 3.75e-05 | 16 | 232 | 4 | PS50868 | |
| Domain | PDZ | 6.82e-05 | 141 | 232 | 9 | PF00595 | |
| Domain | SH3 | PACSIN3 PPP1R13L TRIP10 CASKIN2 CASKIN1 TJP2 MAP3K11 SHANK1 NCKIPSD TNK2 SH3RF3 | 8.52e-05 | 216 | 232 | 11 | SM00326 |
| Domain | SH3 | PACSIN3 PPP1R13L TRIP10 CASKIN2 CASKIN1 TJP2 MAP3K11 SHANK1 NCKIPSD TNK2 SH3RF3 | 8.52e-05 | 216 | 232 | 11 | PS50002 |
| Domain | PDZ | 9.90e-05 | 148 | 232 | 9 | SM00228 | |
| Domain | SH3_domain | PACSIN3 PPP1R13L TRIP10 CASKIN2 CASKIN1 TJP2 MAP3K11 SHANK1 NCKIPSD TNK2 SH3RF3 | 1.00e-04 | 220 | 232 | 11 | IPR001452 |
| Domain | - | 1.10e-04 | 150 | 232 | 9 | 2.30.42.10 | |
| Domain | PDZ | 1.15e-04 | 151 | 232 | 9 | PS50106 | |
| Domain | PDZ | 1.21e-04 | 152 | 232 | 9 | IPR001478 | |
| Domain | EPHD | 1.42e-04 | 22 | 232 | 4 | PS51805 | |
| Domain | Caskin_C | 1.54e-04 | 2 | 232 | 2 | IPR032117 | |
| Domain | MeTrfase_trithorax | 1.54e-04 | 2 | 232 | 2 | IPR016569 | |
| Domain | Caskin-tail | 1.54e-04 | 2 | 232 | 2 | PF16632 | |
| Domain | SAM_DOMAIN | 1.82e-04 | 95 | 232 | 7 | PS50105 | |
| Domain | SAM/pointed | 6.50e-04 | 117 | 232 | 7 | IPR013761 | |
| Domain | SAM | 7.99e-04 | 88 | 232 | 6 | SM00454 | |
| Domain | PHD | 8.48e-04 | 89 | 232 | 6 | SM00249 | |
| Domain | HSA | 9.07e-04 | 4 | 232 | 2 | SM00573 | |
| Domain | HSA | 9.07e-04 | 4 | 232 | 2 | PS51204 | |
| Domain | HSA_dom | 9.07e-04 | 4 | 232 | 2 | IPR014012 | |
| Domain | HSA | 9.07e-04 | 4 | 232 | 2 | PF07529 | |
| Domain | AT_hook | 9.40e-04 | 16 | 232 | 3 | PF02178 | |
| Domain | Znf_PHD | 9.53e-04 | 91 | 232 | 6 | IPR001965 | |
| Domain | ZF_PHD_2 | 1.19e-03 | 95 | 232 | 6 | PS50016 | |
| Domain | ZF_PHD_1 | 1.26e-03 | 96 | 232 | 6 | PS01359 | |
| Domain | SAM | 1.33e-03 | 97 | 232 | 6 | IPR001660 | |
| Domain | Syntrophin | 1.50e-03 | 5 | 232 | 2 | IPR015482 | |
| Domain | SAM_1 | 1.56e-03 | 68 | 232 | 5 | PF00536 | |
| Domain | SET | 1.64e-03 | 41 | 232 | 4 | PF00856 | |
| Pathway | WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME | TBC1D3I TBC1D3G TBC1D3K TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3C TBC1D3B EPOP | 1.75e-07 | 99 | 160 | 10 | M46448 |
| Pathway | REACTOME_TBC_RABGAPS | 9.62e-06 | 44 | 160 | 6 | M27748 | |
| Pathway | REACTOME_RAB_REGULATION_OF_TRAFFICKING | 7.45e-05 | 122 | 160 | 8 | M27872 | |
| Pathway | REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES | 1.07e-04 | 42 | 160 | 5 | M48018 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | VWA5B2 SPIRE2 PDE4A SETD1B KMT2B PCNX3 TMEM94 PIEZO1 FGFRL1 TSC2 SRCAP ARID1A PRAG1 ZDHHC8 GGA3 PPP1R26 PRR12 KMT2C ZNF276 KCNH2 CASKIN1 MAP3K11 CACNA1H KAZALD1 ULK1 ZNF687 SEMA4F HSPG2 CRYBG2 B4GALNT4 PHF12 LMNB2 RASSF7 PHC2 FAM83H ARAP3 SLC2A4RG GAREM2 EPOP TRAPPC12 CTDP1 HELZ2 LRP3 TNK2 IRS2 SNAPC4 SPEN IL4R CEP170B ELL RAI1 | 1.36e-26 | 1105 | 249 | 51 | 35748872 |
| Pubmed | TBC1D3, a hominoid oncoprotein, is encoded by a cluster of paralogues located on chromosome 17q12. | TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B | 2.03e-24 | 11 | 249 | 11 | 16863688 |
| Pubmed | Identification and comparative analysis of multiple mammalian Speedy/Ringo proteins. | 2.09e-10 | 13 | 249 | 6 | 15611625 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | CHAF1B KMT2B BCL7C BPTF ESYT2 RBMX TJP2 KMT2A IRF2BPL NIPBL ZNF687 PHF12 FNBP4 PHC2 TBC1D10B GTF3C1 SLC4A1AP CSNK1E CTDP1 HELZ2 SMARCA2 ANKRD17 IRS2 SNAPC4 SPEN | 4.54e-10 | 774 | 249 | 25 | 15302935 |
| Pubmed | Characterization of a new family of cyclin-dependent kinase activators. | 1.47e-09 | 17 | 249 | 6 | 15574121 | |
| Pubmed | Murine fertility and spermatogenesis are independent of the testis-specific Spdye4a gene. | 2.22e-09 | 9 | 249 | 5 | 36272447 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | SPIRE2 TSC2 UNC45A PRAG1 GLCCI1 ESYT2 CASKIN2 RABGAP1L TJP2 KMT2A MTCL1 PPFIBP1 NCKIPSD RASSF7 FAM83H MLXIPL TBC1D10B SLF2 CSNK1E OTUD7A ANKRD17 IRS2 SH3RF3 CEP170B | 1.77e-08 | 861 | 249 | 24 | 36931259 |
| Pubmed | SETD1B TMEM94 CAMTA2 GGA3 DENND4B RABGAP1L NAV3 CACNA1H MTCL1 ULK1 DLGAP4 FRMPD1 CROCC SPEN CEP170B PDZD2 | 4.94e-08 | 407 | 249 | 16 | 12693553 | |
| Pubmed | DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage. | 6.19e-08 | 74 | 249 | 8 | 16625196 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | CHAF1B KMT2B SRCAP ARID1A PRR12 BPTF KMT2C ESYT2 LIN37 ZNF276 RBMX KAT8 KMT2A NIPBL ZNF687 PHF12 FNBP4 LMNB2 PHC2 MLXIPL KLF16 MISP GTF3C1 EPOP PELP1 SLF2 CSTF2 SPEN RAI1 | 6.42e-08 | 1294 | 249 | 29 | 30804502 |
| Pubmed | 1.76e-07 | 8 | 249 | 4 | 22266653 | ||
| Pubmed | Skirting the pitfalls: a clear-cut nomenclature for H3K4 methyltransferases. | 1.76e-07 | 8 | 249 | 4 | 23130995 | |
| Pubmed | PACSIN3 SYNPO GLCCI1 AJM1 CASKIN1 SYN1 TMEM163 BSN UBQLN2 HCN1 DLGAP4 LNPK CEP170B SNTB2 | 2.52e-07 | 347 | 249 | 14 | 17114649 | |
| Pubmed | 3.14e-07 | 9 | 249 | 4 | 22665483 | ||
| Pubmed | PIEZO1 SYNPO ANKLE2 GGA3 KMT2C NRXN2 TELO2 CASKIN2 CASKIN1 BSN ZNF687 PHF12 FNBP4 SDC3 ANKRD17 EDEM1 RAI1 | 3.30e-07 | 529 | 249 | 17 | 14621295 | |
| Pubmed | 3.63e-07 | 3 | 249 | 3 | 22763696 | ||
| Pubmed | High-throughput analyses of hnRNP H1 dissects its multi-functional aspect. | SPNS2 DZIP1L PACSIN3 CDHR5 SYNPO CAMTA2 IER3 PPP1R37 KAZALD1 CD99L2 OGFR NCKIPSD PKDCC JPH2 TNS2 LMNB2 MLXIPL KLF16 MISP WTIP OTUD7A TNK2 IRS2 ELL | 4.06e-07 | 1021 | 249 | 24 | 26760575 |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | TSC2 SYNPO ZDHHC8 AJM1 CASKIN1 SYN1 TJP2 BSN DLGAP4 LMNB2 CEP170B | 1.00e-06 | 231 | 249 | 11 | 16452087 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | FGFRL1 SYNPO RBBP8NL ARID1A MAP3K12 B4GALT1 SBK1 BPTF KMT2C ESYT2 CACNA1H ASPSCR1 MAN2B2 TOM1 FRMPD1 FNBP4 SLITRK3 MSH5 COL18A1 GTF3C1 SMARCA2 SDC3 ANKRD17 TNK2 CROCC SH3RF3 CEP170B RAI1 PDZD2 | 1.15e-06 | 1489 | 249 | 29 | 28611215 |
| Pubmed | 1.21e-06 | 12 | 249 | 4 | 27563068 | ||
| Pubmed | PRC17, a novel oncogene encoding a Rab GTPase-activating protein, is amplified in prostate cancer. | 1.44e-06 | 4 | 249 | 3 | 12359748 | |
| Pubmed | A subset of mixed lineage leukemia proteins has plant homeodomain (PHD)-mediated E3 ligase activity. | 1.44e-06 | 4 | 249 | 3 | 23129768 | |
| Pubmed | 1.44e-06 | 4 | 249 | 3 | 8406013 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | KMT2B BCL7C ARID1A PRR12 BPTF KMT2C KMT2A NIPBL ZNF703 PHF12 SMARCA2 SPEN RAI1 | 1.76e-06 | 351 | 249 | 13 | 38297188 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | CHAF1B KMT2B BCL7C SYNPO SRCAP GPKOW BPTF KAT8 KMT2A NIPBL KIFC1 PHF12 GTF3C1 SLC4A1AP SNAPC4 SPEN RAI1 | 2.21e-06 | 608 | 249 | 17 | 36089195 |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | GAK SCRT1 TMEM94 PRAG1 MAP3K12 GLCCI1 MAP3K11 KMT2A ULK1 FGFR4 ZNF687 ZDHHC18 PPFIBP1 TNS2 FAM83H GTF3C1 CSNK1E TNK2 BRSK1 SNTB1 SNTB2 | 2.96e-06 | 910 | 249 | 21 | 36736316 |
| Pubmed | 3.29e-06 | 15 | 249 | 4 | 35907431 | ||
| Pubmed | 3.59e-06 | 5 | 249 | 3 | 12604796 | ||
| Pubmed | 3.59e-06 | 5 | 249 | 3 | 25561738 | ||
| Pubmed | 3.59e-06 | 5 | 249 | 3 | 8471161 | ||
| Pubmed | PPP1R13L ANKLE2 GLCCI1 RBMX TJP2 MAP3K11 MTCL1 NIPBL PSRC1 ZNF687 GTF3C1 CTDP1 IRS2 SPEN SNTB2 | 4.09e-06 | 503 | 249 | 15 | 16964243 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | SCARF2 TMEM94 PACSIN3 FGFRL1 CDHR5 ZDHHC8 ESYT2 CASKIN2 PPP1R37 VAT1 PPFIBP1 JPH2 SLITRK3 TBC1D10B SNTB1 PSD4 | 4.11e-06 | 569 | 249 | 16 | 30639242 |
| Pubmed | 4.36e-06 | 16 | 249 | 4 | 23870121 | ||
| Pubmed | 5.06e-06 | 61 | 249 | 6 | 20305087 | ||
| Pubmed | Ajuba LIM proteins are snail/slug corepressors required for neural crest development in Xenopus. | 7.14e-06 | 6 | 249 | 3 | 18331720 | |
| Pubmed | 9.18e-06 | 102 | 249 | 7 | 10231032 | ||
| Pubmed | Genetic interaction mapping in mammalian cells using CRISPR interference. | 1.04e-05 | 69 | 249 | 6 | 28481362 | |
| Pubmed | KMT2B PCNX3 PIEZO1 PACSIN3 UNC45A CUEDC1 PRR12 KMT2C ESYT2 KAT8 KMT2A NIPBL ZNF687 KIFC1 PPFIBP1 PHF12 TOM1 PHC2 COL18A1 SLC4A1AP HELZ2 SMARCA2 ANKRD17 CROCC SPEN CEP170B SNTB2 | 1.11e-05 | 1497 | 249 | 27 | 31527615 | |
| Pubmed | CHAF1B GAK SALL3 KMT2B PCNX3 TMEM94 TTC9B FGFRL1 UNC45A GLCCI1 PIAS3 NRXN2 RABGAP1L NAV3 KMT2A ULK1 BSN NRL PHC2 EPOP CROCC | 1.35e-05 | 1006 | 249 | 21 | 15226823 | |
| Pubmed | ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair. | 1.35e-05 | 150 | 249 | 8 | 28242625 | |
| Pubmed | Structural basis for activity regulation of MLL family methyltransferases. | 1.70e-05 | 22 | 249 | 4 | 26886794 | |
| Pubmed | SETD1B BCL7C ZDHHC8 TTBK1 HSPG2 CARD19 ZBTB47 ZFP36 ELL SNTB2 | 1.83e-05 | 257 | 249 | 10 | 30945288 | |
| Pubmed | 1.88e-05 | 157 | 249 | 8 | 30186101 | ||
| Pubmed | PDE4A ZBTB22 TSC2 SYNPO CASKIN1 SYN1 MTCL1 BSN NIPBL SHANK1 PRR36 HCN1 DLGAP4 LMNB2 PELP1 WTIP ANKRD17 BRSK1 CEP170B RAI1 | 2.34e-05 | 963 | 249 | 20 | 28671696 | |
| Pubmed | 3.02e-05 | 83 | 249 | 6 | 28794006 | ||
| Pubmed | 3.45e-05 | 125 | 249 | 7 | 29467281 | ||
| Pubmed | KMT2B BCL7C SRCAP ARID1A PRR12 BPTF KMT2C LIN37 KAT8 KMT2A IRF2BPL NIPBL ZNF687 KIFC1 ZNF703 HSPG2 PHF12 KLF16 GTF3C1 SMARCA2 CSTF2 ANKRD17 SPEN SNTB1 SNTB2 | 3.94e-05 | 1429 | 249 | 25 | 35140242 | |
| Pubmed | 4.19e-05 | 10 | 249 | 3 | 10744724 | ||
| Pubmed | SPIRE2 PACSIN3 SYNPO PPP1R26 KMT2C ESYT2 CASKIN2 DENND4B IRF2BPL MTCL1 PPFIBP1 TOM1 NCKIPSD PKDCC SLC4A1AP TRAPPC12 | 4.27e-05 | 689 | 249 | 16 | 36543142 | |
| Pubmed | GAK KMT2B UNC45A SRCAP ARID1A GGA3 BPTF KMT2C TJP2 KMT2A FNBP4 GTF3C1 CSTF2 SPEN | 4.79e-05 | 549 | 249 | 14 | 38280479 | |
| Pubmed | 5.11e-05 | 2 | 249 | 2 | 21358644 | ||
| Pubmed | CBFA2T3-ZNF651, like CBFA2T3-ZNF652, functions as a transcriptional corepressor complex. | 5.11e-05 | 2 | 249 | 2 | 20116376 | |
| Pubmed | 5.11e-05 | 2 | 249 | 2 | 37894751 | ||
| Pubmed | 5.11e-05 | 2 | 249 | 2 | 16488127 | ||
| Pubmed | 5.11e-05 | 2 | 249 | 2 | 34910522 | ||
| Pubmed | Macromolecular Complex Including MLL3, Carabin and Calcineurin Regulates Cardiac Remodeling. | 5.11e-05 | 2 | 249 | 2 | 38084599 | |
| Pubmed | 5.11e-05 | 2 | 249 | 2 | 11318604 | ||
| Pubmed | 5.11e-05 | 2 | 249 | 2 | 32604168 | ||
| Pubmed | Expression and clinical significance of ARTN and MMP-9 in endometrial carcinoma. | 5.11e-05 | 2 | 249 | 2 | 29254290 | |
| Pubmed | KMT2A and KMT2B Mediate Memory Function by Affecting Distinct Genomic Regions. | 5.11e-05 | 2 | 249 | 2 | 28723559 | |
| Pubmed | 5.11e-05 | 2 | 249 | 2 | 11031102 | ||
| Pubmed | MLL methyltransferases regulate H3K4 methylation to ensure CENP-A assembly at human centromeres. | 5.11e-05 | 2 | 249 | 2 | 37379335 | |
| Pubmed | 5.11e-05 | 2 | 249 | 2 | 11687802 | ||
| Pubmed | Interleukin-4 activates two distinct pathways of phosphatidylinositol-3 kinase in the same cells. | 5.11e-05 | 2 | 249 | 2 | 8954948 | |
| Pubmed | 5.11e-05 | 2 | 249 | 2 | 21085708 | ||
| Pubmed | Heparan sulfate chains of perlecan are indispensable in the lens capsule but not in the kidney. | 5.11e-05 | 2 | 249 | 2 | 12514129 | |
| Pubmed | 5.11e-05 | 2 | 249 | 2 | 10648423 | ||
| Pubmed | Established and novel Cdk/cyclin complexes regulating the cell cycle and development. | 5.11e-05 | 2 | 249 | 2 | 21630153 | |
| Pubmed | HGFAC is a ChREBP-regulated hepatokine that enhances glucose and lipid homeostasis. | 5.11e-05 | 2 | 249 | 2 | 36413406 | |
| Pubmed | 5.11e-05 | 2 | 249 | 2 | 28467171 | ||
| Pubmed | 5.58e-05 | 57 | 249 | 5 | 18022353 | ||
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | PKD1L1 PPP1R13L SBK1 OTOF RBMX TJP2 MTCL1 EPM2A DCAF10 IRS2 SPEN | 6.59e-05 | 361 | 249 | 11 | 26167880 |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | PACSIN3 TYSND1 PPP1R13L GPKOW GLCCI1 LIN37 TELO2 TJP2 PSRC1 TOM1 NCKIPSD MSH5 RASSF7 ZFP36 MLXIPL ARAP3 CSNK1E IRS2 AJUBA SNTB2 | 6.63e-05 | 1038 | 249 | 20 | 26673895 |
| Pubmed | 7.60e-05 | 12 | 249 | 3 | 36577057 | ||
| Pubmed | 7.60e-05 | 12 | 249 | 3 | 7959747 | ||
| Pubmed | UNC45A ESYT2 TELO2 RBMX RABGAP1L TJP2 ULK1 COL18A1 GTF3C1 TRAPPC12 SNAPC4 CEP170B | 8.33e-05 | 437 | 249 | 12 | 20562859 | |
| Pubmed | 8.99e-05 | 251 | 249 | 9 | 31076518 | ||
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | PCNX3 SCARF2 PACSIN3 ZDHHC8 ESYT2 CASKIN2 VAT1 PPFIBP1 TBC1D10B SNTB1 SNTB2 | 9.67e-05 | 377 | 249 | 11 | 38117590 |
| Pubmed | Tshz1 is required for axial skeleton, soft palate and middle ear development in mice. | 9.83e-05 | 13 | 249 | 3 | 17586487 | |
| Pubmed | 9.83e-05 | 13 | 249 | 3 | 24619213 | ||
| Pubmed | TSC2 ARID1A TJP2 MTCL1 PPFIBP1 NCKIPSD CSNK1E IRS2 SH3RF3 SNTB1 CEP170B SNTB2 | 1.01e-04 | 446 | 249 | 12 | 24255178 | |
| Pubmed | 1.02e-04 | 103 | 249 | 6 | 32744500 | ||
| Pubmed | KMT2B UNC45A PPP1R13L ANKLE2 GGA3 CUEDC1 PPP1R26 PIAS3 PPP1R37 HSPG2 UBQLN2 TOM1 FNBP4 PELP1 | 1.05e-04 | 591 | 249 | 14 | 15231748 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | RBMXL1 PACSIN3 SYNPO UNC45A PPP1R13L GPKOW RBMX TJP2 KIFC1 PPFIBP1 LMNB2 PHC2 FAM83H MISP GTF3C1 PELP1 CSNK1E HELZ2 ANKRD17 AJUBA SPEN SNTB2 | 1.16e-04 | 1257 | 249 | 22 | 36526897 |
| Pubmed | Spatiotemporal Localisation of Heparan Sulphate Proteoglycans throughout Mouse Lens Morphogenesis. | 1.24e-04 | 14 | 249 | 3 | 37408198 | |
| Pubmed | 1.24e-04 | 14 | 249 | 3 | 16452088 | ||
| Pubmed | Proteomic analysis reveals new cardiac-specific dystrophin-associated proteins. | 1.24e-04 | 14 | 249 | 3 | 22937058 | |
| Pubmed | 1.25e-04 | 107 | 249 | 6 | 11347906 | ||
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | ARID1A GPKOW B4GALT1 PRR12 KMT2C RBMX LMNB2 FAM83H SMARCA2 ANKRD17 SNTB2 RAI1 | 1.27e-04 | 457 | 249 | 12 | 32344865 |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | CHAF1B BCL7C ARID1A BPTF KMT2A NIPBL ZNF687 EPM2A PHC2 GTF3C1 PELP1 SMARCA2 CROCC | 1.38e-04 | 533 | 249 | 13 | 30554943 |
| Pubmed | 1.47e-04 | 268 | 249 | 9 | 33640491 | ||
| Pubmed | Type I IL-4Rs selectively activate IRS-2 to induce target gene expression in macrophages. | 1.52e-04 | 3 | 249 | 2 | 19109239 | |
| Pubmed | 1.52e-04 | 3 | 249 | 2 | 11968010 | ||
| Pubmed | Cochlear outer hair cell horizontal top connectors mediate mature stereocilia bundle mechanics. | 1.52e-04 | 3 | 249 | 2 | 30801007 | |
| Pubmed | RBMX is a novel hepatic transcriptional regulator of SREBP-1c gene response to high-fructose diet. | 1.52e-04 | 3 | 249 | 2 | 17188681 | |
| Pubmed | Altered endochondral bone development in matrix metalloproteinase 13-deficient mice. | 1.52e-04 | 3 | 249 | 2 | 15539485 | |
| Pubmed | Tension-dependent regulation of mammalian Hippo signaling through LIMD1. | 1.52e-04 | 3 | 249 | 2 | 29440237 | |
| Pubmed | 1.52e-04 | 3 | 249 | 2 | 10995463 | ||
| Pubmed | Regulation of exosome secretion by Rab35 and its GTPase-activating proteins TBC1D10A-C. | 1.52e-04 | 3 | 249 | 2 | 20404108 | |
| Pubmed | RBMY evolved on the Y chromosome from a ubiquitously transcribed X-Y identical gene. | 1.52e-04 | 3 | 249 | 2 | 10391207 | |
| Interaction | TOP3B interactions | VWA5B2 SPIRE2 PDE4A SETD1B KMT2B PCNX3 TMEM94 PIEZO1 FGFRL1 TSC2 UNC45A SRCAP ARID1A PRAG1 ZDHHC8 GGA3 PPP1R26 PRR12 KMT2C ZNF276 KCNH2 CASKIN1 MAP3K11 CACNA1H KAZALD1 ULK1 ZNF687 SEMA4F HSPG2 CRYBG2 B4GALNT4 PHF12 LMNB2 RASSF7 ZFP36 PHC2 FAM83H ARAP3 SLC2A4RG GAREM2 EPOP PELP1 TRAPPC12 CTDP1 HELZ2 LRP3 ANKRD17 TNK2 IRS2 SNAPC4 SPEN IL4R CEP170B ELL RAI1 | 2.62e-15 | 1470 | 231 | 55 | int:TOP3B |
| Interaction | NFIX interactions | KMT2B BCL7C SRCAP ARID1A PRR12 BPTF KMT2C KMT2A NIPBL PHF12 GTF3C1 SMARCA2 SPEN | 2.33e-06 | 227 | 231 | 13 | int:NFIX |
| Interaction | ELF1 interactions | 1.51e-05 | 126 | 231 | 9 | int:ELF1 | |
| Interaction | YWHAG interactions | SPIRE2 DZIP1L BAG1 TSC2 SYNPO PRAG1 GLCCI1 ESYT2 TTBK1 GRID2IP CASKIN2 RABGAP1L TJP2 KMT2A MTCL1 ULK1 PPFIBP1 NCKIPSD TNS2 RASSF7 ZFP36 FAM83H MLXIPL TBC1D10B CSNK1E OTUD7A ANKRD17 TNK2 IRS2 SH3RF3 CEP170B PSD4 | 1.62e-05 | 1248 | 231 | 32 | int:YWHAG |
| Interaction | HNF4A interactions | KMT2B BCL7C SRCAP ARID1A PRR12 BPTF KMT2C LIN37 KAT8 NIPBL PHF12 SMARCA2 SPEN | 1.85e-05 | 275 | 231 | 13 | int:HNF4A |
| Interaction | YWHAH interactions | SPIRE2 BAG1 TSC2 UNC45A PRAG1 GLCCI1 ESYT2 GRID2IP CASKIN2 KCNH2 RABGAP1L TJP2 KMT2A MTCL1 PPFIBP1 NCKIPSD TNS2 RASSF7 ZFP36 FAM83H MLXIPL TBC1D10B SLF2 CSNK1E OTUD7A ANKRD17 IRS2 SH3RF3 CEP170B | 2.62e-05 | 1102 | 231 | 29 | int:YWHAH |
| Interaction | ASF1A interactions | CHAF1B KMT2B SRCAP ARID1A ANKLE2 KAT8 KMT2A ZNF687 GTF3C1 SPEN ELL RAI1 | 3.22e-05 | 249 | 231 | 12 | int:ASF1A |
| Interaction | MAPK8IP1 interactions | 5.23e-05 | 58 | 231 | 6 | int:MAPK8IP1 | |
| Interaction | TBXT interactions | 5.79e-05 | 116 | 231 | 8 | int:TBXT | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q12 | TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B EPOP | 4.49e-11 | 149 | 251 | 12 | chr17q12 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q11 | SPDYE11 SPDYE13 SPDYE15 SPDYE21 SPDYE5 SPDYE14 SPDYE17 SPDYE10 DNAJC30 SPDYE9 SPDYE18 SPDYE12 MLXIPL SPDYE8 | 4.01e-10 | 271 | 251 | 14 | chr7q11 |
| Cytoband | 7q11.23 | 6.78e-08 | 97 | 251 | 8 | 7q11.23 | |
| Cytoband | 17q12 | 1.84e-05 | 99 | 251 | 6 | 17q12 | |
| Cytoband | 16q24 | 1.04e-04 | 17 | 251 | 3 | 16q24 | |
| Cytoband | 4p16 | 1.04e-04 | 17 | 251 | 3 | 4p16 | |
| Cytoband | 16p13.3 | 4.20e-04 | 244 | 251 | 7 | 16p13.3 | |
| Cytoband | 11p15.5 | 4.97e-04 | 118 | 251 | 5 | 11p15.5 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16q24 | 9.44e-04 | 136 | 251 | 5 | chr16q24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | KMT2B TTC9B PPP1R13L TMEM91 PRR12 SELENOV LIN37 PPP1R37 SHANK1 LILRB3 ZNF446 ZFP36 WTIP DACT3 LRP3 BRSK1 | 9.62e-04 | 1192 | 251 | 16 | chr19q13 |
| Cytoband | 19p13.3 | 2.03e-03 | 237 | 251 | 6 | 19p13.3 | |
| GeneFamily | Speedy/RINGO cell cycle regulator family | 1.41e-12 | 12 | 145 | 7 | 756 | |
| GeneFamily | PDZ domain containing | 3.79e-06 | 152 | 145 | 9 | 1220 | |
| GeneFamily | Sterile alpha motif domain containing | 7.57e-05 | 88 | 145 | 6 | 760 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 1.53e-04 | 34 | 145 | 4 | 487 | |
| GeneFamily | PHD finger proteins | 7.87e-04 | 90 | 145 | 5 | 88 | |
| GeneFamily | DNAJ (HSP40) heat shock proteins|C2 tensin-type domain containing | 1.73e-03 | 8 | 145 | 2 | 837 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | KMT2B TMEM94 TSC2 ARID1A BPTF KMT2C TMEM245 ULK1 CNNM1 GTF3C1 PELP1 | 9.53e-07 | 180 | 241 | 11 | M8239 |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | KMT2B PCNX3 PIEZO1 FGFRL1 ARID1A ANKLE2 B4GALT1 ESYT2 TMEM245 CD99L2 KIFC1 HSPG2 VASN PPFIBP1 ZFP36 GTF3C1 HELZ2 LTBP2 IL4R RAI1 | 5.61e-06 | 681 | 241 | 20 | M5314 |
| Coexpression | TABULA_MURIS_SENIS_SUBCUTANEOUS_ADIPOSE_TISSUE_EPITHELIAL_CELL_AGEING | PDE4A BCL7C CDHR5 CAMTA2 ANKLE2 BPTF IER3 PPP1R37 PHLPP1 MAP3K11 IRF2BPL SPINDOC UBQLN2 PHF12 FAM83H KLF16 SMO CEP170B | 5.99e-06 | 568 | 241 | 18 | MM3824 |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | KMT2B PCNX3 PIEZO1 FGFRL1 ARID1A ANKLE2 B4GALT1 ESYT2 TMEM245 CD99L2 KIFC1 HSPG2 VASN PPFIBP1 ZFP36 GTF3C1 HELZ2 LTBP2 IL4R RAI1 | 8.94e-06 | 703 | 241 | 20 | MM1055 |
| CoexpressionAtlas | Mesoderm Day 5_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | SCARF2 PRAG1 FGFR4 TBC1D3G TBC1D3K TBC1D3F HSPG2 TBC1D3 TBC1D3H TBC1D3L TBC1D3D VASN PKDCC TBC1D3C TBC1D3B COL18A1 AJUBA SNTB1 RAI1 | 3.53e-09 | 320 | 236 | 19 | PCBC_ratio_MESO-5_vs_DE_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 15_vs_Mesoderm Day 30-Confounder_removed-fold2.0_adjp0.05 | TBC1D3G TBC1D3K TBC1D3F TBC1D3 TBC1D3H TBC1D3L TBC1D3D VWCE TBC1D3C TBC1D3B | 6.25e-08 | 90 | 236 | 10 | PCBC_ratio_MESO-15_vs_MESO-30_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | CACNA1H SPDYE2B TBC1D3G TBC1D3K TBC1D3F TBC1D3 TBC1D3H TBC1D3L TBC1D3D VASN TBC1D3C TBC1D3B COL18A1 SPDYE2 SNAPC4 SPDYE6 | 1.12e-07 | 281 | 236 | 16 | PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | CACNA1H SPDYE2B TBC1D3G TBC1D3K TBC1D3F TBC1D3 TBC1D3H TBC1D3L TBC1D3D VASN TBC1D3C TBC1D3B COL18A1 SPDYE2 SNAPC4 SPDYE6 | 1.12e-07 | 281 | 236 | 16 | PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | SCARF2 PIEZO1 BCL7C ZBTB22 FAM174B FGFRL1 PPP1R13L PRAG1 ZDHHC8 TRIP10 B4GALT1 VENTX IER3 TBC1D3G TBC1D3K TBC1D3F HSPG2 TBC1D3 TBC1D3H TBC1D3L TBC1D3D VASN PPFIBP1 TBC1D3C RASSF7 TBC1D3B ZFP36 COL18A1 SLC2A4RG WTIP SDC3 BRSK1 RAI1 | 5.92e-07 | 1153 | 236 | 33 | PCBC_ratio_MESO-5_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | Endoderm Differentiated Cells-method_mRNA_vs_Endoderm Differentiated Cells-method_NA-Confounder_removed-fold2.0_adjp0.05 | SCARF2 VENTX TBC1D3G TBC1D3K TBC1D3F TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B RAI1 | 5.00e-06 | 213 | 236 | 12 | PCBC_ratio_DE_from-mRNA_vs_DE_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Endoderm Differentiated Cells-reprogram_OSKM-L_vs_Endoderm Differentiated Cells-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | SCARF2 VENTX TBC1D3G TBC1D3K TBC1D3F TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B RAI1 | 5.00e-06 | 213 | 236 | 12 | PCBC_ratio_DE_from-OSKM-L_vs_DE_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | facebase_RNAseq_e9.5_MaxArch_2500 | CHAF1B RBMXL1 TMEM94 BCL7C FGFRL1 SYNPO UNC45A TYSND1 GLCCI1 GGA3 SBK1 PRR12 KCNH2 MAP3K11 FGFR4 PSRC1 KIFC1 ZNF703 UBQLN2 PKDCC LMNB2 MSX1 MLXIPL ARAP3 EPOP CSNK1E WFIKKN1 CTDP1 DACT3 LRP3 SDC3 IRS2 CROCC RAI1 | 9.21e-06 | 1371 | 236 | 34 | facebase_RNAseq_e9.5_MaxArch_2500 |
| CoexpressionAtlas | facebase_RNAseq_e9.5_MaxArch_2500_K4 | CHAF1B RBMXL1 TMEM94 BCL7C FGFRL1 SYNPO UNC45A TYSND1 GLCCI1 GGA3 SBK1 PRR12 KCNH2 MAP3K11 PSRC1 KIFC1 ZNF703 UBQLN2 PKDCC LMNB2 MLXIPL EPOP CSNK1E CTDP1 DACT3 LRP3 IRS2 CROCC RAI1 | 2.22e-05 | 1125 | 236 | 29 | facebase_RNAseq_e9.5_MaxArch_2500_K4 |
| CoexpressionAtlas | DE cord blood_vs_DE blastocyst-Confounder_removed-fold2.0_adjp0.05 | VENTX TBC1D3G TBC1D3K TBC1D3F B4GALNT4 TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B | 8.87e-05 | 242 | 236 | 11 | PCBC_ratio_DE cord blood_vs_DE blastocyst_cfr-2X-p05 |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | CENPA TMEM94 BCL7C ZBTB22 FGFRL1 IRF7 PPP1R13L CUEDC1 IER3 CACNA1H TBC1D3G CD99L2 TBC1D3K TBC1D3F ZNF703 TBC1D3 TBC1D3H TBC1D3L TBC1D3D VASN TBC1D3C TBC1D3B ZFP36 MSX1 PIANP SLC2A4RG WTIP WFIKKN1 LTBP2 BRSK1 AJUBA RAI1 | 1.94e-04 | 1466 | 236 | 32 | PCBC_ratio_ECTO_vs_SC_cfr-2X-p05 |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | HGFAC PACSIN3 FGFRL1 CDHR5 ST6GALNAC6 FGFR4 VWCE FAM83H COL18A1 IRS2 | 7.47e-08 | 182 | 246 | 10 | 77ab860e2add49dad0c1ffbfc64278ad499dfbd5 |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | HGFAC PACSIN3 FGFRL1 CDHR5 ST6GALNAC6 FGFR4 VWCE FAM83H COL18A1 IRS2 | 7.47e-08 | 182 | 246 | 10 | 4921c7d5687cc79f896b39753bb621d7e3d2972f |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | HGFAC PACSIN3 FGFRL1 CDHR5 ST6GALNAC6 FGFR4 VWCE FAM83H COL18A1 IRS2 | 7.47e-08 | 182 | 246 | 10 | 770ce9f3f4538d0181a0181543841bc964c68274 |
| ToppCell | 3'-Adult-Distal_Rectal-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.12e-06 | 189 | 246 | 9 | 43e131458d8a4b120f7a5fb3d0c5650abded15f6 | |
| ToppCell | 3'-Adult-Distal_Rectal-Mesenchymal-Pericytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.12e-06 | 189 | 246 | 9 | d69b7a01dd4d6ad043bb6210e9ab34b49578389c | |
| ToppCell | 3'-Adult-Distal_Rectal-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.12e-06 | 189 | 246 | 9 | 2b5f1b4f173a224342ea4f10b193ee33b7662699 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-Pericytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.34e-06 | 193 | 246 | 9 | 7631bf3362b4fa061ffeab4879ab12c4708dc4c0 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.34e-06 | 193 | 246 | 9 | 8d15c63f2ae48d0a00d7ef5fdafa917ab8ad0571 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-06 | 193 | 246 | 9 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-06 | 193 | 246 | 9 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-06 | 193 | 246 | 9 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | CV-Moderate-6|CV / Virus stimulation, Condition and Cluster | 1.52e-06 | 196 | 246 | 9 | 7bced0cc2112697593c478fa291b8ed3941fb811 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.65e-06 | 198 | 246 | 9 | 7dd874b09c81cc512ccc1e9b65f290a5f94d736e | |
| ToppCell | Transverse-Macrophage-LYVE1_Macrophage|Transverse / Region, Cell class and subclass | 1.72e-06 | 199 | 246 | 9 | facf79c256db5ae57bdb613e86ec90616a6f67ca | |
| ToppCell | Transverse-(6)_Macrophage-(61)_LYVE1_Macrophage|Transverse / shred on region, Cell_type, and subtype | 1.72e-06 | 199 | 246 | 9 | dcc2a7f4d1fa30aaaad655dd59c5a2b039d264bf | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 1.79e-06 | 200 | 246 | 9 | c92e4fc0442404481fcac623d691dae6215b852d | |
| ToppCell | TCGA-Mesothelium-Primary_Tumor-Mesothelioma-Biphasic|TCGA-Mesothelium / Sample_Type by Project: Shred V9 | 4.27e-06 | 167 | 246 | 8 | 9062577a4b7902c9a888d706589d1b05221c0fa8 | |
| ToppCell | PND28-Endothelial-Endothelial_lymphatic|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.54e-06 | 173 | 246 | 8 | 2978c744d3c8dcaa2b9bb225abf846f82e8f9176 | |
| ToppCell | PND28-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.54e-06 | 173 | 246 | 8 | 23d4a315a0ad5c6fc77bcfc18b6c1ff55be99e8f | |
| ToppCell | PND28-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.54e-06 | 173 | 246 | 8 | 03b50b2376d353748a32bf14a9fc8341ea61dbca | |
| ToppCell | PND28-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.54e-06 | 173 | 246 | 8 | 12da47b90aecedaa31764ff7ddb853ee39123e9d | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.56e-06 | 177 | 246 | 8 | 2b63f0529ef73e0eede9b7ef1f08b0a0426a9c82 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.83e-06 | 178 | 246 | 8 | 1bddbc083c36657bd6910f7466126ab325e88176 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.83e-06 | 178 | 246 | 8 | a74e5a390cbeaca9de1fdb7b2a0e50783bd202dd | |
| ToppCell | facs-Liver-Hepatocytes-24m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.37e-06 | 183 | 246 | 8 | d0721c6aa426953a520d40e976b6e65aa7ca65e8 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.02e-05 | 188 | 246 | 8 | c90669b51e1902fe7726555290c91c92a911df83 | |
| ToppCell | CV-Severe-1|Severe / Virus stimulation, Condition and Cluster | 1.48e-05 | 198 | 246 | 8 | 9b9ee0b0f6cc92e7be94869604c98f43d57ff8ff | |
| ToppCell | Epithelial_cells-AT1-AT2_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 1.48e-05 | 198 | 246 | 8 | fbc46b20bcd44f2083170aacbc6f5dd00fba685c | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Fibroblasts-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.84e-05 | 158 | 246 | 7 | 7f5426585d0d299d2b48e5fcb349950feffdef33 | |
| ToppCell | mild_COVID-19_(asymptomatic)-pDC|World / disease group, cell group and cell class (v2) | 4.04e-05 | 167 | 246 | 7 | bf08f17965a4dd03f371b4ed0ab0d5e62ed61307 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l15|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.87e-05 | 172 | 246 | 7 | de4961f4037c439d3e0ec706a257b0ec17f4d5be | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.24e-05 | 174 | 246 | 7 | 9f2e253694eb5860c00528fda31c305c6de8a2a1 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-Smooth_muscle_cells|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 5.44e-05 | 175 | 246 | 7 | fed9e4120c758fdcc23bb248d1801002b0e0d485 | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-goblet-BEST2+_Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.44e-05 | 175 | 246 | 7 | 019ea30ac55748463d7917abf3d3f0e804189bfd | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.63e-05 | 176 | 246 | 7 | 533d544852038c0612aacf87f4b1c88ff7aace82 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.72e-05 | 121 | 246 | 6 | e57b026794130aa69b67f6170bcd5093f885fdb1 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.84e-05 | 177 | 246 | 7 | 8ef41ee5d63737b810ad7371b0437625e7e1badf | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-goblet|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.05e-05 | 178 | 246 | 7 | 9099b47e0756d6a1b7ba1c6aa7b47c5425f649e0 | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.49e-05 | 180 | 246 | 7 | a37cc885fe3f6cb9df69d43358064c83c18412e7 | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.49e-05 | 180 | 246 | 7 | 63a6d532b16b8b15c7c9102148d7297ee3afd641 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Cycling_Myeloid-Mac|lymph-node_spleen / Manually curated celltypes from each tissue | 6.49e-05 | 180 | 246 | 7 | 4eea8366cdb82c356325ce88f09ad8b302c17a07 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Early_airway_SMC_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.20e-05 | 183 | 246 | 7 | a1d4f25e13f5b9e92a9ca0a804a7bed5df8fb2fe | |
| ToppCell | Pericytes-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 7.20e-05 | 183 | 246 | 7 | 4617b18da8d699a44e4c47980197b1e7eb951470 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 7.20e-05 | 183 | 246 | 7 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.45e-05 | 184 | 246 | 7 | 603faafb7b289a3c0242c84fc800c050c8a092ea | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response-SM_activated_stress_response_L.2.3.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.45e-05 | 184 | 246 | 7 | c350504bfe0ec31cd2fc2199de9b5fff151a8c5e | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.45e-05 | 184 | 246 | 7 | 590fb32bb1f348ea5fa2aece30ebe1e212512991 | |
| ToppCell | COVID-19-kidney-FLT1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.71e-05 | 185 | 246 | 7 | 673308ca0514a4d3629d61fe91e9d8fb31b72166 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-EECs|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.71e-05 | 185 | 246 | 7 | d42f6722a6771752cd744146a09e2ead9b7252bc | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-Like-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.82e-05 | 128 | 246 | 6 | 2cf0384240a4a663869cf6b27d954236f6214a9a | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.97e-05 | 186 | 246 | 7 | bd1185592aedebccd1007dbf2dd2f549fcdf9f42 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.97e-05 | 186 | 246 | 7 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.97e-05 | 186 | 246 | 7 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 7.97e-05 | 186 | 246 | 7 | 9d3efe2a4feea2bc205a7e45b9b9f9ed9b3609ce | |
| ToppCell | Substantia_nigra-Neuronal|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 7.97e-05 | 186 | 246 | 7 | 3f889083fcffe516388e9b03a5e23af2010ced33 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.97e-05 | 186 | 246 | 7 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|368C / Donor, Lineage, Cell class and subclass (all cells) | 8.25e-05 | 187 | 246 | 7 | b827d9da7032bf051756ddf88352af922eb0f87b | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 8.25e-05 | 187 | 246 | 7 | 61c00604dda8b36a5c3eea6554e5601aa1b884f7 | |
| ToppCell | Pericytes-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 8.53e-05 | 188 | 246 | 7 | f16ff998393bf1954bbf10caab15173bdb104ac1 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 8.53e-05 | 188 | 246 | 7 | b73e8a40393c3f656e2fcfe395a761b1f985c254 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.81e-05 | 189 | 246 | 7 | 965e0e388251e7318f8b463816dc96ccb4658677 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.81e-05 | 189 | 246 | 7 | f75cebd4c3e54e297557449ba67ccc8d1a2a14f5 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.81e-05 | 189 | 246 | 7 | f57200c93d39c9bce1adba0a6a1c178c028dd86b | |
| ToppCell | Globus_pallidus-Neuronal|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 9.11e-05 | 190 | 246 | 7 | 416de85d8841dac883faa6f5339b2fb461a09e82 | |
| ToppCell | RA-06._Ventricular_Cardiomyocyte_II|RA / Chamber and Cluster_Paper | 9.26e-05 | 132 | 246 | 6 | 82674ec4b0a416e4f08372b86c2a475afe3f38a5 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.41e-05 | 191 | 246 | 7 | 60bc1f3efa7bbad5cb7944fe5e049ea79cd1745a | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.72e-05 | 192 | 246 | 7 | 0bf99e029a06151092db1e8a0dcb45f4e688e771 | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.72e-05 | 192 | 246 | 7 | d766221acfce30cbf2c60b3ae40f6744968b952c | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.00e-04 | 193 | 246 | 7 | 323d1f3f4fbeb93ba857fc135d8aa0b897f98ac5 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.00e-04 | 193 | 246 | 7 | adc9fc94f9ec686a417d08c0b8b7b7ab687afec0 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Smooth_muscle|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.07e-04 | 195 | 246 | 7 | b3660779f274ca97dd844cf83f62d85ba88cb182 | |
| ToppCell | CV-Moderate-6|Moderate / Virus stimulation, Condition and Cluster | 1.07e-04 | 195 | 246 | 7 | 2b8a72d7e755b9655c7a496000d10ff06e50862b | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Smooth_muscle-Smooth_muscle_L.2.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.07e-04 | 195 | 246 | 7 | 7155cc12cc6a97efd626bbdb95249fb3d7041dcf | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.07e-04 | 195 | 246 | 7 | a52ee3ad6cd317f10b9308450517861ef2e363bb | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.11e-04 | 196 | 246 | 7 | ce6f7ddb8104471dc90347f427486379914d63b4 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.11e-04 | 196 | 246 | 7 | f78951b460913866d092ba92af70ea76a2afa73e | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Smooth_muscle-Smooth_muscle_L.2.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.11e-04 | 196 | 246 | 7 | 4da96672a9c72268cfcc82d61eb3caae6e02d4c4 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.11e-04 | 196 | 246 | 7 | 70b2e0b4ff4f1bc03fb72ace07a8a44f4b415922 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-04 | 196 | 246 | 7 | 9554ac6eb5f381bcde3ba40c32aa3fc340974540 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Epithelial-luminal_progenitor_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-04 | 196 | 246 | 7 | 22fcfb713f402ebbd43b2822f0fd919cdbfba6e4 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response-SM_activated_stress_response_L.2.3.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.11e-04 | 196 | 246 | 7 | ac4c8571bd792538f8df7b9bdd90ef58405fd3b1 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Smooth_muscle|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.11e-04 | 196 | 246 | 7 | 69ad90a429af4dad5a45556544224001ebcb1607 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-Pericytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.11e-04 | 196 | 246 | 7 | 6d7179decea512dd49bb2d5f6a4f5989349d52a9 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.14e-04 | 197 | 246 | 7 | d16bb765afdc02406ffd7ce6a75bae72b66db66c | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.14e-04 | 197 | 246 | 7 | 01249bd485a3734de87ae6ed9c749597f39c6335 | |
| ToppCell | cellseq-Mesenchymal-Myocytic-Myocytic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.18e-04 | 198 | 246 | 7 | c7075dce915ab8387309fcb12c5f6a17d4100cda | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.18e-04 | 198 | 246 | 7 | 1e1ea54f0c234f3b6d29064c4881d8a0c0949a75 | |
| ToppCell | cellseq-Mesenchymal-Myocytic-Myocytic_2-VSMC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.18e-04 | 198 | 246 | 7 | e967c601101361fc1c48dab0e5b76dc68813276e | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-2|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.21e-04 | 199 | 246 | 7 | 706b7de777ff86eb22e538ccd5c2987ceb6be308 | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Smooth_muscle-2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.21e-04 | 199 | 246 | 7 | c8bc05dece8b8a87d4a7a3e8112b924e15217de1 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Smooth_muscle-2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.21e-04 | 199 | 246 | 7 | 78b245d40c1e169ff2d26907b63d732e34529c5f | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Smooth_muscle-2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.21e-04 | 199 | 246 | 7 | 8e1e95c3a4b856415af208be6ad977e575bac189 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-2|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.21e-04 | 199 | 246 | 7 | 471738f2059e20407572d9c4cbd11812068333ea | |
| ToppCell | Sepsis-Leuk-UTI-Lymphocyte-T/NK-CD4+_CTL|Leuk-UTI / Disease, condition lineage and cell class | 1.21e-04 | 199 | 246 | 7 | b2609f9d716fdd04f35f0da7f8995d28d7df431d | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.21e-04 | 199 | 246 | 7 | 690a4f84b205532c4c9e5c19d5ae430d0655f421 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Pericyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.25e-04 | 200 | 246 | 7 | d70bad979299615fcba707ba21296020918705e6 | |
| ToppCell | distal-mesenchymal-Airway_Smooth_Muscle-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.25e-04 | 200 | 246 | 7 | f09eaa52e11262ec47f3dcb4d890e240eaaa2b3d | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Peri/Epineurial_-NAF_epineurial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.25e-04 | 200 | 246 | 7 | be46efc899d06c55ee297bee3126f69bcdb2048b | |
| ToppCell | medial-2-mesenchymal-Airway_Smooth_Muscle|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.25e-04 | 200 | 246 | 7 | 16b00eacbea4d75cf814803d3fc0b82c2b8c0a9c | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.25e-04 | 200 | 246 | 7 | 38c21ec379005f688df33aea65237a063c476c2e | |
| Drug | Paroxetine maleate [64006-44-6]; Down 200; 1uM; PC3; HT_HG-U133A | KMT2B PIEZO1 CUEDC1 ZNF276 NAV3 FGFR4 TCTN1 CSNK1E CTDP1 TNK2 SPEN IL4R | 9.97e-07 | 197 | 234 | 12 | 4556_DN |
| Drug | Chlorambucil [305-03-3]; Down 200; 13.2uM; MCF7; HT_HG-U133A | SRCAP NPFFR1 KCNH2 KAT8 RABGAP1L CACNA1H HSPG2 EPM2A OGFR DLGAP4 ZNF446 PHC2 | 1.05e-06 | 198 | 234 | 12 | 3869_DN |
| Drug | DO 897/99; Down 200; 8.2uM; MCF7; HT_HG-U133A | PDE4A KCNH2 NIPBL SEMA4F ZDHHC18 OGFR PPFIBP1 DLGAP4 TNS2 LRP3 TNK2 SNAPC4 | 1.05e-06 | 198 | 234 | 12 | 2877_DN |
| Drug | Diprophylline [479-18-5]; Down 200; 15.8uM; PC3; HT_HG-U133A | ZNF276 CASKIN2 KMT2A ASPSCR1 FGFR4 OGFR DLGAP4 RASSF7 ZFP36 LRP3 IL4R | 6.23e-06 | 196 | 234 | 11 | 5063_DN |
| Drug | 2-propylpentanoic acid; Down 200; 200uM; MCF7; HT_HG-U133A | TELO2 CASKIN2 KAT8 RABGAP1L KAZALD1 OGFR TNS2 ZNF446 CSNK1E IRS2 IL4R | 6.54e-06 | 197 | 234 | 11 | 5211_DN |
| Drug | (-)-Cinchonidine [485-71-2]; Down 200; 13.6uM; MCF7; HT_HG-U133A | NPFFR1 GGA3 KCNN1 KMT2A KAZALD1 OGFR GPR143 ARTN SNAPC4 IL4R PSD4 | 6.54e-06 | 197 | 234 | 11 | 2772_DN |
| Drug | LY 294002; Down 200; 10uM; MCF7; HT_HG-U133A | SRCAP KCNH2 DENND4B RABGAP1L KAZALD1 DLGAP4 ARTN ZNF446 IRS2 IL4R CEP170B | 6.54e-06 | 197 | 234 | 11 | 5236_DN |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | 2.29e-05 | 185 | 234 | 10 | 5585_DN | |
| Drug | fullerene C60 | VWA5B2 PIEZO1 PACSIN3 IRF7 SRCAP CUEDC1 VENTX TELO2 CASKIN2 PPP1R37 SYN1 IRF2BPL ULK1 FGFR4 BSN ZNF703 LILRB3 B4GALNT4 UBQLN2 TOM1 PKDCC ZBTB47 MSH5 ZFP36 PHC2 LDB3 GTF3C1 HELZ2 SDC3 PWWP3A SH3RF3 IL4R PDZD2 | 2.85e-05 | 1498 | 234 | 33 | ctd:C069837 |
| Drug | CP-690334-01 [459212-38-5]; Down 200; 1uM; MCF7; HT_HG-U133A | 3.58e-05 | 195 | 234 | 10 | 3909_DN | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A | ZNF276 CASKIN2 KMT2A EPM2A DLGAP4 ARTN ZNF446 CSNK1E IL4R PSD4 | 3.58e-05 | 195 | 234 | 10 | 1650_UP |
| Drug | Pirenzepine dihydrochloride [29868-97-1]; Down 200; 9.4uM; PC3; HT_HG-U133A | CAMTA2 SRCAP CUEDC1 CASKIN2 NAV3 KMT2A TCTN1 CSNK1E SDC3 SNAPC4 | 3.58e-05 | 195 | 234 | 10 | 2071_DN |
| Drug | (-)-Isoproterenol hydrochloride [5984-95-2]; Down 200; 16.2uM; PC3; HT_HG-U133A | GGA3 CUEDC1 CASKIN2 NAV3 ASPSCR1 KAZALD1 ZDHHC18 OGFR SNAPC4 CROCC | 3.58e-05 | 195 | 234 | 10 | 4495_DN |
| Drug | Cephapirin sodium salt [24356-60-3]; Down 200; 9uM; MCF7; HT_HG-U133A | PDE4A CAMTA2 MAP3K12 CASKIN2 OGFR DLGAP4 GPR143 SLF2 CTDP1 TNK2 | 3.74e-05 | 196 | 234 | 10 | 3471_DN |
| Drug | Clorsulon [60200-06-8]; Up 200; 10.6uM; MCF7; HT_HG-U133A | SRCAP MAP3K12 KCNH2 CACNA1H ASPSCR1 FGFR4 PRR36 ZNF446 COL18A1 TNK2 | 3.74e-05 | 196 | 234 | 10 | 2884_UP |
| Drug | Yohimbine hydrochloride [65-19-0]; Down 200; 10.2uM; PC3; HT_HG-U133A | SETD1B KMT2B MAP3K12 RABGAP1L NIPBL MAN2B2 RASSF7 SLC4A1AP TNK2 EDEM1 | 3.91e-05 | 197 | 234 | 10 | 7130_DN |
| Drug | Amidopyrine [58-15-1]; Up 200; 17.2uM; PC3; HT_HG-U133A | FAM174B CAMTA2 GPKOW CASKIN2 ASPSCR1 FGFR4 NIPBL TCTN1 PRR36 ARTN | 4.08e-05 | 198 | 234 | 10 | 2060_UP |
| Drug | 2-propylpentanoic acid; Down 200; 50uM; MCF7; HT_HG-U133A | NPFFR1 B4GALT1 LIN37 KAT8 OGFR TOM1 ZNF446 CTDP1 IRS2 SNAPC4 | 4.08e-05 | 198 | 234 | 10 | 5582_DN |
| Drug | 2-propylpentanoic acid; Down 200; 50uM; MCF7; HT_HG-U133A | FAM174B ARID1A CUEDC1 RABGAP1L ASPSCR1 MTCL1 FGFR4 OGFR ARTN COL18A1 | 4.26e-05 | 199 | 234 | 10 | 6982_DN |
| Drug | Acetaminophen [103-90-2]; Up 200; 26.4uM; MCF7; HT_HG-U133A | SETD1B SRCAP CACNA1H KAZALD1 FGFR4 HSPG2 OGFR ARTN ZNF446 SDC3 | 4.26e-05 | 199 | 234 | 10 | 5384_UP |
| Drug | Ifosfamide [3778-73-2]; Down 200; 15.4uM; MCF7; HT_HG-U133A | CAMTA2 B4GALT1 KCNH2 RABGAP1L KAZALD1 GPR143 TNS2 ARTN IRS2 CEP170B | 4.26e-05 | 199 | 234 | 10 | 3485_DN |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | SETD1B ARID1A B4GALT1 KAZALD1 EPM2A ARTN CBFA2T3 ZNF446 PSD4 | 7.55e-05 | 172 | 234 | 9 | 5903_DN |
| Drug | 6,7-dimethoxy-2-(pyrrolidin-1-yl)-N-(5-(pyrrolidin-1-yl)pentyl)quinazolin-4-amine | 1.01e-04 | 104 | 234 | 7 | ctd:C000595015 | |
| Drug | ZD7288 | 1.22e-04 | 10 | 234 | 3 | CID000123983 | |
| Drug | Spiperone [749-02-0]; Down 200; 10.2uM; PC3; HT_HG-U133A | 1.37e-04 | 186 | 234 | 9 | 5777_DN | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Up 200; 11uM; MCF7; HT_HG-U133A | 1.55e-04 | 189 | 234 | 9 | 3408_UP | |
| Drug | Homochlorcyclizine dihydrochloride [1982-36-1]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 1.67e-04 | 191 | 234 | 9 | 7417_UP | |
| Drug | Estriol [50-27-1]; Down 200; 13.8uM; MCF7; HT_HG-U133A | TMEM94 PPP1R13L CASKIN2 ZDHHC18 DLGAP4 TBC1D10B SMARCA2 LRP3 IL4R | 1.67e-04 | 191 | 234 | 9 | 7220_DN |
| Drug | vinblastine sulfate; Up 200; 0.1uM; PC3; HT_HG-U133A | 1.74e-04 | 192 | 234 | 9 | 7556_UP | |
| Drug | 15d-PGJ2; Down 200; 10uM; MCF7; HT_HG-U133A | KMT2B CAMTA2 ZNF276 ASPSCR1 KAZALD1 MTCL1 EPM2A ARTN CBFA2T3 | 1.74e-04 | 192 | 234 | 9 | 6990_DN |
| Drug | Amethopterin (R,S) [59-05-2]; Down 200; 8.8uM; HL60; HG-U133A | 1.74e-04 | 192 | 234 | 9 | 1599_DN | |
| Drug | Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; MCF7; HT_HG-U133A | PPP1R13L CASKIN2 CACNA1H HSPG2 CNNM1 COL18A1 TBC1D10B CTDP1 ELL | 1.81e-04 | 193 | 234 | 9 | 3262_UP |
| Drug | felodipine; Down 200; 10uM; MCF7; HT_HG-U133A_EA | CAMTA2 PPP1R13L ASPSCR1 FGFR4 SEMA4F OGFR RASSF7 SMARCA2 PWWP3A | 1.81e-04 | 193 | 234 | 9 | 965_DN |
| Drug | Conessine [546-06-5]; Down 200; 11.2uM; MCF7; HT_HG-U133A | SRCAP ARID1A B4GALT1 CASKIN2 KCNH2 RABGAP1L DLGAP4 NCKIPSD CSNK1E | 1.88e-04 | 194 | 234 | 9 | 2792_DN |
| Drug | Halcinonide [3093-35-4]; Up 200; 8.8uM; PC3; HT_HG-U133A | 1.88e-04 | 194 | 234 | 9 | 7379_UP | |
| Drug | Indoprofen [31842-01-0]; Down 200; 14.2uM; PC3; HT_HG-U133A | 1.88e-04 | 194 | 234 | 9 | 4249_DN | |
| Drug | Pipenzolate bromide [125-51-9]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 1.88e-04 | 194 | 234 | 9 | 3460_DN | |
| Drug | clofibrate; Up 200; 150uM; MCF7; HG-U133A | 1.88e-04 | 194 | 234 | 9 | 263_UP | |
| Drug | Metolazone [17560-51-9]; Down 200; 11uM; MCF7; HT_HG-U133A | 1.96e-04 | 195 | 234 | 9 | 1514_DN | |
| Drug | Mefexamide hydrochloride [3413-64-7]; Up 200; 12.6uM; PC3; HT_HG-U133A | 1.96e-04 | 195 | 234 | 9 | 2121_UP | |
| Drug | GSK-3 Inhibitor IX; Up 200; 0.5uM; MCF7; HT_HG-U133A | 1.96e-04 | 195 | 234 | 9 | 7101_UP | |
| Drug | ICI182,780; Down 200; 1uM; PC3; HT_HG-U133A | 1.96e-04 | 195 | 234 | 9 | 5969_DN | |
| Drug | Aconitine [302-27-2]; Down 200; 6.2uM; MCF7; HT_HG-U133A | 1.96e-04 | 195 | 234 | 9 | 2776_DN | |
| Drug | Sulfamethoxypyridazine [80-35-3]; Down 200; 14.2uM; MCF7; HT_HG-U133A | PDE4A OGFR DLGAP4 NCKIPSD RASSF7 SLC4A1AP SLF2 SMARCA2 EDEM1 | 1.96e-04 | 195 | 234 | 9 | 3409_DN |
| Drug | Chlorambucil [305-03-3]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 1.96e-04 | 195 | 234 | 9 | 4345_DN | |
| Drug | Bumetanide [28395-03-1]; Down 200; 11uM; PC3; HT_HG-U133A | 1.96e-04 | 195 | 234 | 9 | 5117_DN | |
| Drug | Protriptyline hydrochloride [1225-55-4]; Down 200; 13.4uM; HL60; HT_HG-U133A | 1.96e-04 | 195 | 234 | 9 | 3119_DN | |
| Drug | nocodazole; Up 200; 1uM; MCF7; HG-U133A | FAM174B B4GALT1 CASKIN2 CACNA1H ULK1 OGFR ARTN CSNK1E SNAPC4 | 1.96e-04 | 195 | 234 | 9 | 621_UP |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.03e-04 | 196 | 234 | 9 | 3872_DN | |
| Drug | Tetrahydroalstonine [6474-90-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | 2.03e-04 | 196 | 234 | 9 | 5728_DN | |
| Drug | Tetracycline hydrochloride [64-75-5]; Down 200; 8.4uM; PC3; HT_HG-U133A | 2.03e-04 | 196 | 234 | 9 | 5757_DN | |
| Drug | Propylthiouracil [51-52-5]; Down 200; 23.4uM; MCF7; HT_HG-U133A | 2.11e-04 | 197 | 234 | 9 | 2837_DN | |
| Drug | Monensin sodium salt [22373-78-0]; Down 200; 5.8uM; PC3; HT_HG-U133A | 2.11e-04 | 197 | 234 | 9 | 3704_DN | |
| Drug | PNU-0293363 [326823-19-2]; Up 200; 10uM; PC3; HT_HG-U133A | 2.11e-04 | 197 | 234 | 9 | 6563_UP | |
| Drug | Zalcitabine [7481-89-2]; Down 200; 19uM; HL60; HT_HG-U133A | 2.11e-04 | 197 | 234 | 9 | 2932_DN | |
| Drug | Indoprofen [31842-01-0]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 2.11e-04 | 197 | 234 | 9 | 4832_DN | |
| Drug | Amitryptiline hydrochloride [549-18-8]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 2.11e-04 | 197 | 234 | 9 | 5453_DN | |
| Drug | Flecainide acetate [54143-56-5]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 2.11e-04 | 197 | 234 | 9 | 3937_DN | |
| Drug | Gallamine triethiodide [65-29-2]; Down 200; 4.4uM; PC3; HT_HG-U133A | 2.11e-04 | 197 | 234 | 9 | 2059_DN | |
| Drug | Heliotrine [303-33-3]; Down 200; 12.8uM; PC3; HT_HG-U133A | 2.11e-04 | 197 | 234 | 9 | 4277_DN | |
| Drug | Isoxicam [34552-84-6]; Down 200; 12uM; MCF7; HT_HG-U133A | 2.11e-04 | 197 | 234 | 9 | 1698_DN | |
| Drug | Cefazolin sodium salt [27164-46-1]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 2.19e-04 | 198 | 234 | 9 | 3426_DN | |
| Drug | Diperodon hydrochloride [537-12-2]; Down 200; 9.2uM; PC3; HT_HG-U133A | 2.19e-04 | 198 | 234 | 9 | 4498_DN | |
| Drug | Hydroquinine hydrobromide hydrate [304695-81-6]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 2.19e-04 | 198 | 234 | 9 | 6263_UP | |
| Drug | Cisapride [81098-60-4]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 2.19e-04 | 198 | 234 | 9 | 3305_DN | |
| Drug | Alverine citrate salt [5560-59-8]; Up 200; 8.4uM; PC3; HT_HG-U133A | 2.19e-04 | 198 | 234 | 9 | 6345_UP | |
| Drug | Canrenoic acid potassium salt [2181-04-6]; Up 200; 10uM; PC3; HT_HG-U133A | 2.19e-04 | 198 | 234 | 9 | 2065_UP | |
| Drug | 16, 16-dimethylprostaglandin E2 methyl acetate solution; Up 200; 10uM; MCF7; HT_HG-U133A | 2.19e-04 | 198 | 234 | 9 | 6597_UP | |
| Drug | Dipyrone [5907-38-0]; Up 200; 12uM; MCF7; HT_HG-U133A | 2.19e-04 | 198 | 234 | 9 | 3929_UP | |
| Drug | Isocarboxazid [59-63-2]; Up 200; 17.2uM; PC3; HT_HG-U133A | 2.19e-04 | 198 | 234 | 9 | 7383_UP | |
| Drug | PF-00562151-00 [351320-12-2]; Up 200; 10uM; PC3; HT_HG-U133A | 2.19e-04 | 198 | 234 | 9 | 6907_UP | |
| Drug | nordihydroguaiaretic acid; Down 200; 1uM; MCF7; HT_HG-U133A | 2.19e-04 | 198 | 234 | 9 | 6983_DN | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | 2.19e-04 | 198 | 234 | 9 | 1650_DN | |
| Drug | Quinidine hydrochloride monohydrate [6151-40-2]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 2.19e-04 | 198 | 234 | 9 | 6267_UP | |
| Drug | Dizocilpine maleate [77086-22-7]; Down 200; 11.8uM; PC3; HT_HG-U133A | 2.19e-04 | 198 | 234 | 9 | 2069_DN | |
| Drug | Baclofen (R,S) [1134-47-0]; Down 200; 18.8uM; MCF7; HT_HG-U133A | 2.28e-04 | 199 | 234 | 9 | 1536_DN | |
| Drug | Vidarabine [5536-17-4]; Down 200; 15uM; MCF7; HT_HG-U133A | CAMTA2 RABGAP1L ASPSCR1 MMP9 PSRC1 COL18A1 SMARCA2 LRP3 SNAPC4 | 2.28e-04 | 199 | 234 | 9 | 7203_DN |
| Drug | Carbamazepine [298-46-4]; Down 200; 17uM; MCF7; HT_HG-U133A | ZNF276 CASKIN2 KAT8 RABGAP1L TOM1 NCKIPSD ARTN RASSF7 SMARCA2 | 2.28e-04 | 199 | 234 | 9 | 1683_DN |
| Drug | Bephenium hydroxynaphthoate [3818-50-6]; Up 200; 9uM; MCF7; HT_HG-U133A | 2.28e-04 | 199 | 234 | 9 | 6466_UP | |
| Drug | Riluzole hydrochloride; Down 200; 14.8uM; PC3; HT_HG-U133A | FAM174B SYNPO CUEDC1 CASKIN2 OGFR TNS2 RASSF7 COL18A1 CSNK1E | 2.28e-04 | 199 | 234 | 9 | 7365_DN |
| Drug | Khellin [82-02-0]; Up 200; 15.4uM; PC3; HT_HG-U133A | 2.28e-04 | 199 | 234 | 9 | 6641_UP | |
| Drug | Methylatropine nitrate [52-88-0]; Down 200; 11uM; MCF7; HT_HG-U133A | 2.28e-04 | 199 | 234 | 9 | 6495_DN | |
| Drug | Tinidazole [19387-91-8]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 2.28e-04 | 199 | 234 | 9 | 3430_DN | |
| Drug | Gentamicine sulfate [1405-41-0]; Up 200; 2.6uM; PC3; HT_HG-U133A | 2.36e-04 | 200 | 234 | 9 | 2082_UP | |
| Drug | sodium 4-phenylbutyrate; Down 200; 1000uM; HL60; HG-U133A | 2.36e-04 | 200 | 234 | 9 | 411_DN | |
| Disease | physical activity | 4.98e-06 | 88 | 224 | 7 | EFO_0003940 | |
| Disease | Liver carcinoma | HGFAC CHAF1B KMT2B CENPA ARID1A KMT2C KMT2A MMP9 KIFC1 VASN MSH5 ZFP36 MLXIPL IRS2 | 3.72e-05 | 507 | 224 | 14 | C2239176 |
| Disease | autosomal recessive nonsyndromic deafness 16 (implicated_via_orthology) | 5.74e-05 | 2 | 224 | 2 | DOID:0110471 (implicated_via_orthology) | |
| Disease | triglycerides in small LDL measurement | 1.37e-04 | 65 | 224 | 5 | EFO_0022323 | |
| Disease | creatinine measurement | HGFAC CHAF1B SPIRE2 ARID1A B4GALT1 NRXN2 MAP3K11 FGFR4 KLHDC7A BSN ZDHHC18 OGFR PHC2 COL18A1 TBC1D10B SLF2 TNK2 ELL PSD4 | 2.30e-04 | 995 | 224 | 19 | EFO_0004518 |
| Disease | testosterone measurement | HGFAC PDE4A SPNS2 BCL7C FGFRL1 SRCAP ARID1A GGA3 VENTX TTBK1 FAM186A ZNF703 ZDHHC18 UBQLN2 DLGAP4 FNBP4 MLXIPL SLC2A4RG SLC4A1AP TRAPPC12 SMARCA2 RAI1 | 3.05e-04 | 1275 | 224 | 22 | EFO_0004908 |
| Disease | nasopharynx carcinoma (is_marker_for) | 3.16e-04 | 43 | 224 | 4 | DOID:9261 (is_marker_for) | |
| Disease | tuberous sclerosis (is_marker_for) | 3.41e-04 | 4 | 224 | 2 | DOID:13515 (is_marker_for) | |
| Disease | muscular dystrophy (implicated_via_orthology) | 5.19e-04 | 21 | 224 | 3 | DOID:9884 (implicated_via_orthology) | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 5.65e-04 | 5 | 224 | 2 | C3281201 | |
| Disease | anodontia (is_implicated_in) | 5.65e-04 | 5 | 224 | 2 | DOID:13714 (is_implicated_in) | |
| Disease | Klatskin's tumor (is_implicated_in) | 5.65e-04 | 5 | 224 | 2 | DOID:4927 (is_implicated_in) | |
| Disease | triglycerides in medium VLDL measurement | 8.14e-04 | 55 | 224 | 4 | EFO_0022155 | |
| Disease | Abnormality of vision | 8.43e-04 | 6 | 224 | 2 | C4025846 | |
| Disease | childhood absence epilepsy (biomarker_via_orthology) | 8.43e-04 | 6 | 224 | 2 | DOID:1825 (biomarker_via_orthology) | |
| Disease | triglycerides in LDL measurement | 8.72e-04 | 56 | 224 | 4 | EFO_0022320 | |
| Disease | C-reactive protein measurement | HGFAC CENPA TTC9B PRAG1 SBK1 BPTF ZNF469 ZNF276 PPP1R37 BSN CABP1 ZDHHC18 PRSS55 XKR6 MLXIPL SLC4A1AP IRS2 SNAPC4 IL4R PSD4 | 9.37e-04 | 1206 | 224 | 20 | EFO_0004458 |
| Disease | Adenoid Cystic Carcinoma | 1.01e-03 | 100 | 224 | 5 | C0010606 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.11e-03 | 152 | 224 | 6 | DOID:0060041 (implicated_via_orthology) | |
| Disease | total lipids in VLDL measurement | 1.13e-03 | 60 | 224 | 4 | EFO_0022314 | |
| Disease | X-24328 measurement | 1.17e-03 | 7 | 224 | 2 | EFO_0800873 | |
| Disease | triglycerides in small VLDL measurement | 1.20e-03 | 61 | 224 | 4 | EFO_0022145 | |
| Disease | Schizophrenia | PDE4A PSD BAG1 ZDHHC8 NRXN2 KCNH2 TMEM245 KAT8 SYN1 KMT2A GRIN3A MMP9 SHANK1 CSNK1E SMARCA2 RAI1 | 1.24e-03 | 883 | 224 | 16 | C0036341 |
| Disease | Craniofacial Abnormalities | 1.26e-03 | 156 | 224 | 6 | C0376634 | |
| Disease | prostate cancer (is_marker_for) | 1.26e-03 | 156 | 224 | 6 | DOID:10283 (is_marker_for) | |
| Disease | phospholipids in large VLDL measurement | 1.28e-03 | 62 | 224 | 4 | EFO_0022169 | |
| Disease | triglycerides in medium LDL measurement | 1.28e-03 | 62 | 224 | 4 | EFO_0022322 | |
| Disease | level of Sphingomyelin (d42:2) in blood serum | 1.36e-03 | 29 | 224 | 3 | OBA_2045183 | |
| Disease | cholesterol in large VLDL measurement | 1.52e-03 | 65 | 224 | 4 | EFO_0021902 | |
| Disease | cholesterol in very large VLDL measurement | 1.52e-03 | 65 | 224 | 4 | EFO_0022230 | |
| Disease | Cornelia De Lange Syndrome | 1.56e-03 | 8 | 224 | 2 | C0270972 | |
| Disease | Pitt-Rogers-Danks Syndrome | 1.56e-03 | 8 | 224 | 2 | C0796117 | |
| Disease | Ovarian Mucinous Adenocarcinoma | 1.66e-03 | 31 | 224 | 3 | C1335167 | |
| Disease | total lipids in large VLDL | 1.70e-03 | 67 | 224 | 4 | EFO_0022175 | |
| Disease | free cholesterol in large VLDL measurement | 1.80e-03 | 68 | 224 | 4 | EFO_0022265 | |
| Disease | phospholipids:total lipids ratio | 1.82e-03 | 227 | 224 | 7 | EFO_0020946 | |
| Disease | C-C motif chemokine 18 measurement | 1.99e-03 | 9 | 224 | 2 | EFO_0008046 | |
| Disease | Wolf-Hirschhorn Syndrome | 1.99e-03 | 9 | 224 | 2 | C1956097 | |
| Disease | alkaline phosphatase measurement | FGFRL1 TSC2 PRAG1 CASKIN1 PPP1R37 MMP9 HSPG2 ZDHHC18 B4GALNT4 PRSS55 XKR6 MLXIPL SLC4A1AP SLF2 LTBP2 EDEM1 RAI1 | 2.03e-03 | 1015 | 224 | 17 | EFO_0004533 |
| Disease | Intellectual Disability | 2.33e-03 | 447 | 224 | 10 | C3714756 | |
| Disease | interstitial lung disease (is_implicated_in) | 2.48e-03 | 10 | 224 | 2 | DOID:3082 (is_implicated_in) | |
| Disease | Burkitt Lymphoma | 2.56e-03 | 36 | 224 | 3 | C0006413 | |
| Disease | Alzheimer disease, educational attainment | 2.91e-03 | 247 | 224 | 7 | EFO_0011015, MONDO_0004975 | |
| Disease | level of Sphingomyelin (d34:0) in blood serum | 3.02e-03 | 11 | 224 | 2 | OBA_2045176 | |
| Disease | Marfan Syndrome | 3.02e-03 | 11 | 224 | 2 | C0024796 | |
| Disease | aspirin use measurement | 3.23e-03 | 39 | 224 | 3 | EFO_0007013 | |
| Disease | neuroimaging measurement | VWA5B2 SPIRE2 KMT2B FGFRL1 GLCCI1 ZNF469 DENND4B NAV3 MAP3K11 PKDCC MSH5 COL18A1 MLXIPL SMARCA2 SH3RF3 SNTB2 RAI1 | 3.44e-03 | 1069 | 224 | 17 | EFO_0004346 |
| Disease | Global developmental delay | 3.53e-03 | 133 | 224 | 5 | C0557874 | |
| Disease | rheumatoid arthritis (implicated_via_orthology) | 3.60e-03 | 12 | 224 | 2 | DOID:7148 (implicated_via_orthology) | |
| Disease | esophagus adenocarcinoma (is_marker_for) | 3.60e-03 | 12 | 224 | 2 | DOID:4914 (is_marker_for) | |
| Disease | rotator cuff tear | 3.60e-03 | 12 | 224 | 2 | EFO_1001250 | |
| Disease | Carcinoma, Transitional Cell | 3.72e-03 | 41 | 224 | 3 | C0007138 | |
| Disease | neuroticism measurement | PACSIN3 PRAG1 RABGAP1L KMT2A TMEM163 UBQLN2 HCN1 FNBP4 PRSS55 MSH5 XKR6 CBFA2T3 EPOP LTBP2 LNPK | 4.21e-03 | 909 | 224 | 15 | EFO_0007660 |
| Disease | Coffin-Siris syndrome | 4.24e-03 | 13 | 224 | 2 | C0265338 | |
| Disease | male infertility (implicated_via_orthology) | 4.24e-03 | 13 | 224 | 2 | DOID:12336 (implicated_via_orthology) | |
| Disease | skin melanoma (is_marker_for) | 4.24e-03 | 13 | 224 | 2 | DOID:8923 (is_marker_for) | |
| Disease | IGF-1 measurement | PDE4A SRCAP ARID1A NPFFR1 SBK1 DNAJC30 MLXIPL GAREM2 ASCL2 IL4R | 4.34e-03 | 488 | 224 | 10 | EFO_0004627 |
| Disease | Bladder Neoplasm | 4.39e-03 | 140 | 224 | 5 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 4.52e-03 | 141 | 224 | 5 | C0005684 | |
| Disease | PR interval | PCNX3 SYNPO2L ZNF469 CASKIN2 HSPG2 CRYBG2 HCN1 LMNB2 LDB3 OTUD7A | 4.79e-03 | 495 | 224 | 10 | EFO_0004462 |
| Disease | interleukin 17 measurement | 4.84e-03 | 45 | 224 | 3 | EFO_0008174 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 4.84e-03 | 45 | 224 | 3 | DOID:3748 (is_implicated_in) | |
| Disease | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | 4.92e-03 | 14 | 224 | 2 | EFO_0004611, EFO_0008589 | |
| Disease | cortical thickness | VWA5B2 SPIRE2 KMT2B FGFRL1 ZNF469 NAV3 KMT2A MTCL1 HSPG2 PPFIBP1 PKDCC XKR6 COL18A1 SH3RF3 SNTB1 ELL PDZD2 | 5.13e-03 | 1113 | 224 | 17 | EFO_0004840 |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 5.54e-03 | 148 | 224 | 5 | C0279702 | |
| Disease | Anilide use measurement | 5.64e-03 | 15 | 224 | 2 | EFO_0009938 | |
| Disease | African Burkitt's lymphoma | 5.64e-03 | 15 | 224 | 2 | C0343640 | |
| Disease | pancreas fat measurement | 5.64e-03 | 15 | 224 | 2 | EFO_0600049 | |
| Disease | Burkitt Leukemia | 5.64e-03 | 15 | 224 | 2 | C4721444 | |
| Disease | myopathy (implicated_via_orthology) | 5.81e-03 | 48 | 224 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 7.05e-03 | 291 | 224 | 7 | EFO_0008317, EFO_0020946 | |
| Disease | cortical surface area measurement | SPIRE2 PCNX3 FGFRL1 ZNF469 NAV3 MTCL1 PPFIBP1 PRSS55 PKDCC PERM1 MSH5 XKR6 PHC2 DMRT2 EPOP AJUBA SH3RF3 SNTB1 PDZD2 | 7.16e-03 | 1345 | 224 | 19 | EFO_0010736 |
| Disease | ocular hypertension (biomarker_via_orthology) | 7.24e-03 | 17 | 224 | 2 | DOID:9282 (biomarker_via_orthology) | |
| Disease | alpha-L-iduronidase measurement | 7.24e-03 | 17 | 224 | 2 | EFO_0020139 | |
| Disease | Familial Progressive Myoclonic Epilepsy | 7.24e-03 | 17 | 224 | 2 | C0751777 | |
| Disease | Atypical Inclusion-Body Disease | 7.24e-03 | 17 | 224 | 2 | C0751776 | |
| Disease | Myoclonic Epilepsies, Progressive | 7.24e-03 | 17 | 224 | 2 | C0751778 | |
| Disease | Biotin-Responsive Encephalopathy | 7.24e-03 | 17 | 224 | 2 | C0751780 | |
| Disease | May-White Syndrome | 7.24e-03 | 17 | 224 | 2 | C0751782 | |
| Disease | Dentatorubral-Pallidoluysian Atrophy | 7.24e-03 | 17 | 224 | 2 | C0751781 | |
| Disease | pancreatic cancer (is_marker_for) | 7.44e-03 | 101 | 224 | 4 | DOID:1793 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SSLEPGRPAAPSLPG | 501 | Q9Y5B0 | |
| SARAPSPPRPGGPEN | 86 | A0FGR8 | |
| LRPAPPTGASASGRP | 166 | B3EWF7 | |
| GARPPPPLGASSQPR | 81 | P15291 | |
| GLGRSGTPVPPPSAA | 41 | Q86XL3 | |
| RLGGPPGPTRPLTSS | 251 | Q9BZE9 | |
| GREALLPTPGPPAST | 361 | P55199 | |
| GGPGVSRSPEPSPRP | 121 | Q8WWN8 | |
| RPPPPTSRLPEGCGG | 6 | Q8N4J0 | |
| EGSFPAGPPPTRALP | 86 | Q96IF1 | |
| RESRPPPGPGPGNTT | 41 | Q3ZCQ3 | |
| RPPGPDLSPDGPRSS | 566 | P22455 | |
| GRTRPPPHAAPDGPT | 556 | C9J069 | |
| HRGSSPGPRPVEGTP | 406 | Q13112 | |
| PSPAPLEPSSRVGRG | 471 | O94983 | |
| PPPSGRPPARSTASG | 41 | Q99933 | |
| PGPGAARGPSPSSPT | 96 | Q86VQ1 | |
| PAGPGTSTPPSSPVR | 266 | Q96G46 | |
| GVRAPSPAPSSVPLG | 2396 | O75179 | |
| SPAGPESSRRSGPGP | 711 | Q9Y4F5 | |
| GPHPPSGTTLRPPTS | 501 | Q9HBB8 | |
| RPPTSSTPGGPPGAE | 511 | Q9HBB8 | |
| DTRGPVPGPRGPIPS | 466 | P33240 | |
| PPAPPSTSAPGRGGR | 81 | Q12830 | |
| PSPSSPLPPARGRDG | 156 | Q9NZU7 | |
| TRPPSVTRGGVAPAP | 616 | Q9Y2H0 | |
| GPAAAAPGSPSVPRP | 31 | Q8TE57 | |
| PQGSRTPSPLVPPGS | 786 | Q07912 | |
| RPSAPRGPPGTTPVA | 126 | Q99929 | |
| RGPPGTTPVAASPSR | 131 | Q99929 | |
| LSRPGPAAPVTPTPG | 136 | Q02833 | |
| TALSEPRTPGPPGLT | 1061 | Q7Z5J4 | |
| PAPGGAPPIRIEPSS | 2821 | P98160 | |
| SSSRGPLPVKRGPPP | 141 | P38159 | |
| RSGGPPPKRSAPSGP | 156 | P38159 | |
| PAAPGPAVPSSGRAP | 56 | Q9Y4B5 | |
| PRGAPTPSPAARGAP | 246 | Q9Y4B5 | |
| TPSPAARGAPPGSPE | 251 | Q9Y4B5 | |
| GIRGPSPSPVGSPAS | 691 | O14497 | |
| APRPGLHGPSSTPPS | 591 | Q8IYY4 | |
| ESGPSSGAPRPGRLP | 386 | Q9GZQ6 | |
| DHGDPRTPGPPRSTP | 166 | Q8IVT2 | |
| GPPTVHPSERPTAGP | 471 | P14780 | |
| HPSERPTAGPTGPPS | 476 | P14780 | |
| GHPTPRPASPEPGRV | 1026 | Q8WXD9 | |
| ETPRPEGGSPSPAGT | 476 | Q9BR39 | |
| VVLTPPPTGARPSPG | 21 | Q96I82 | |
| ARREAASPGTPGPPP | 46 | Q9BXK1 | |
| GPPPGSANPPRLVSS | 4146 | Q8NEZ4 | |
| APTPAPSTIPGPRRG | 16 | P46695 | |
| PTPPGPPGDACRSRI | 166 | Q96GY3 | |
| ARASPGTPGTPELRP | 126 | O75112 | |
| PFGTLPPRPPGQDTS | 496 | Q86W92 | |
| AEGTAPSPGRVSPPT | 31 | Q9H7Z6 | |
| PSPGRVSPPTPARGE | 36 | Q9H7Z6 | |
| PGRAGGPATPLSPTR | 26 | Q03252 | |
| LGSAPRSPAPREGPP | 41 | Q5T4W7 | |
| PARPSPGSPRGQPQD | 51 | Q92952 | |
| GPGSPPRSAPGQLPS | 236 | Q12809 | |
| AARSTAVPPVPGPGP | 51 | Q9UPA5 | |
| SGPGGPSDPPTRLSL | 336 | Q9BW19 | |
| SPGPSPGMTPGTPRS | 51 | P0DPD6 | |
| RAPSAPPGTGALPPA | 516 | Q9H1B7 | |
| IPTEGPRTSRPPGPG | 1911 | Q9H6A9 | |
| PRTSRPPGPGLLSSE | 1916 | Q9H6A9 | |
| APPLPGHRPPGTARD | 411 | Q8N441 | |
| ITPRRSPGPPAGGVS | 2516 | O15018 | |
| SPSPPPEEESRGPGH | 686 | P27815 | |
| ALRPPQPPSSGPSDG | 396 | Q8IVL0 | |
| GTLPAPTPSPPSLGR | 186 | P39060 | |
| TPPPRIDALGSGAPT | 151 | Q9NWM3 | |
| RPGAPSLSPAPRSGE | 56 | Q5QP82 | |
| EPSEGRPGPPTASLG | 26 | P54845 | |
| PAGSEGTPKGSRPPL | 281 | Q6KC79 | |
| DTLPPPAARRPPSGG | 1461 | Q9P2S2 | |
| RPPSAPGRAPEVGPS | 666 | O75074 | |
| QPPARPPGPSTDTGA | 81 | Q92917 | |
| PARPLLPFSTGPGSP | 546 | Q9NZ52 | |
| RAGPEGTSPPTPTPS | 486 | Q9UMN6 | |
| SLPPTGPPSTPGLGR | 426 | O75022 | |
| PPSSRGGGPPPEAET | 71 | Q92985 | |
| RASASGPVPGRSPPA | 751 | Q8TE49 | |
| GPVPGRSPPAPARQS | 756 | Q8TE49 | |
| SVPPGRGALPPDSLS | 296 | Q6PGN9 | |
| AGSAGPSRPGSPSPP | 631 | O75081 | |
| SAGPVPSARPGPPTT | 691 | Q8IZL8 | |
| GGLPPPPRAVPSSSS | 81 | Q04756 | |
| RPVPPPRPESTGTVG | 1126 | Q8WXE0 | |
| EISTPRPSSPGGLPE | 111 | Q5R372 | |
| PEPGTRRSPAPSPGA | 81 | Q8TCU5 | |
| APVSPRSPSGTPAPG | 286 | P0CG20 | |
| LVPPTDSLGPGDRSP | 531 | O75864 | |
| AGSPLSPGPVRAPLS | 386 | Q9Y4H2 | |
| RGPANGTPPPLPARS | 236 | Q8NC74 | |
| APPLSVQSTPRGGPP | 941 | O14976 | |
| LGRAPSPAPRPVPGS | 1446 | Q5TZA2 | |
| SSGAIPPNRGVPPAP | 846 | O60741 | |
| TTPLRAPDPSPGGVP | 756 | P24394 | |
| PGSGPAAPTTVLRAP | 91 | A4D2P6 | |
| PPGPSPAVTTGPRTL | 581 | A4D2P6 | |
| GGTPQPSRPVSPAGP | 116 | Q8WUZ0 | |
| AARVPGPGPSPSAPQ | 496 | Q96B18 | |
| PRPPLAPQASPAGTG | 86 | Q9Y5R5 | |
| RPGTTRAPAKPPGSG | 56 | Q8TCZ2 | |
| TPTPGPSRRGPSLGA | 21 | P49450 | |
| RPPSPPAGLSTEPAG | 181 | A6NHQ4 | |
| TEPAGPGTAPRPFLP | 191 | A6NHQ4 | |
| PGPPSGPRDVSTAEP | 781 | Q5SYB0 | |
| GRRPAGPGSPATSPP | 51 | P51810 | |
| SVDRVSPSPGGTPAP | 711 | Q8N1P7 | |
| ASAPPQRPPSGPEGR | 146 | Q96LW7 | |
| RSTPPGRPGNPSEPD | 36 | A6NJJ6 | |
| SARSTPLPGPPGSPR | 496 | Q8TDC3 | |
| PGTAHGAQTPPPTRP | 166 | P0C7T7 | |
| LRSPDGPASPTSGPV | 46 | Q92611 | |
| PPARGDTPPSEGSAP | 636 | Q12852 | |
| GTPQRSGAAPPTPPR | 146 | Q14767 | |
| SGAAPPTPPRGRLTG | 151 | Q14767 | |
| HRGDTTSPSRPPGGP | 976 | Q9Y2E5 | |
| PGALPVPGPSRSAPS | 721 | O75064 | |
| VPSPRPPPGSLGTGA | 316 | Q5VTJ3 | |
| SPGCRPLPSAGSPTP | 2156 | Q03164 | |
| PTRPPASVSPAARGG | 21 | Q96LR7 | |
| GSPRTPPPTSRTHDG | 136 | Q96LL9 | |
| SPGQLPISRAPPTPG | 1821 | A6NE01 | |
| SPGPTHNSPELGRPP | 1061 | Q6ZRV2 | |
| PAPTASPRPGPSSLG | 2016 | Q9BYK8 | |
| VRAGAPPSPPSPGRG | 551 | O95180 | |
| DPTRPPRATDTPGPG | 741 | O95180 | |
| PRATDTPGPGPGSPQ | 746 | O95180 | |
| PERSTLPLGTTAPGP | 271 | O75056 | |
| SGSRPAPPAVGSVPL | 361 | Q52WX2 | |
| PLSRPESGASTPGGP | 291 | Q9BXA9 | |
| SSLGRAPSPRPGPGP | 151 | Q8WUF5 | |
| GDSSGSSPPRAPPLP | 46 | Q5SV97 | |
| PTSPRSSHGLPPGIP | 241 | Q8TDX9 | |
| GPGRERGESPTTPPT | 666 | Q16584 | |
| PPPGTSRSAPGTPGT | 741 | Q16584 | |
| SRSAPGTPGTPRSPP | 746 | Q16584 | |
| GLLPGSRPSSRPPGE | 151 | Q9HC10 | |
| TRDGTAPPPQSPGSP | 331 | Q9UKS6 | |
| PEGLVGPSSPRPSPL | 341 | Q7Z6I6 | |
| GRPKPSPAGSRGSPV | 71 | O43364 | |
| ESPSETPGPRPAGPA | 536 | Q9NZT2 | |
| ESPSETPGPRPAGPA | 556 | Q9NZT2 | |
| TPGPSPAGPTRDEPA | 581 | Q9NZT2 | |
| ESPSETPGPRPAGPA | 596 | Q9NZT2 | |
| ESPSETPGPRPAGPA | 616 | Q9NZT2 | |
| TPGPSPAGPTRDEPA | 641 | Q9NZT2 | |
| SSGFPSPAPVPGPRE | 21 | O43196 | |
| AGPGSPTRSAPPGPA | 36 | Q5JXM2 | |
| GSGRLSSSPPVPPRF | 496 | Q75VX8 | |
| SPGPGPGPRESVTPR | 326 | Q2TAK8 | |
| GLGPRPRSPSPTPSL | 781 | Q9H987 | |
| PRTGPPTTQQPRPSG | 611 | P17600 | |
| PPESPRLGGSTSDPP | 216 | Q13884 | |
| RPGDRAPSSPLPGVP | 796 | Q7Z5M5 | |
| SSSRGPLPVKRGPPP | 141 | Q96E39 | |
| PPPTPRPELATAAGG | 86 | Q9BWW7 | |
| GQSPEPSPAPGPGRR | 36 | Q504Y2 | |
| GVSPPRPTPALGPGS | 131 | A5PKW4 | |
| ARPRPGPGQPTASPF | 6 | O95754 | |
| RPSGPGPELSGPSTP | 261 | P51531 | |
| QLSPPGPRGSTPGRD | 16 | Q8N3X1 | |
| GSLGAPDAPSSPRPL | 101 | P28360 | |
| GPPRHPSPQSPDRGV | 226 | Q8N3V7 | |
| PTPTPDHEEPRGGPR | 246 | Q8IYJ0 | |
| PTPGPDTSVSGPRLT | 1081 | Q9H6K5 | |
| GGGRPTLSSPEKAPP | 721 | O94933 | |
| GPPLTDSRPLGSPPN | 651 | Q96QT6 | |
| PSSPESESRGPGPRP | 446 | Q8NDX1 | |
| PGPRPSPASSQEGSP | 456 | Q8NDX1 | |
| GPSAPGVDPSPPRRS | 41 | P0DUX0 | |
| GPSAPGVDPSPPRRS | 41 | P0DTA3 | |
| GPSAPGVDPSPPRRS | 41 | P0DUD1 | |
| EPTSLPPGPPAGRRH | 11 | Q969X2 | |
| PGCLGRTPQPGSPSP | 626 | Q9Y4R8 | |
| QPGFRGPTPPSSRPS | 551 | Q9UPS6 | |
| SGSVRRAPTGPPGTP | 61 | Q8IVW8 | |
| AESPSPAPPPGLRGT | 306 | Q9BUA3 | |
| PARGDPVPPRSTSGG | 931 | Q5T8A7 | |
| PAPGSSPPRCHLRPG | 16 | Q8IX21 | |
| VSSEAGPAPGPLPTR | 181 | P59797 | |
| GGATRPPPPRSTATP | 401 | Q9ULL5 | |
| PVASPIGPRSPGPSH | 1931 | Q6ZRS2 | |
| PPRAPRSSTPCPGGA | 406 | B9A6J9 | |
| PGPGTLSVRVSPPQP | 621 | Q9NP71 | |
| GPSAPGVDPSPPCRS | 51 | A6NHP3 | |
| GGPPTPTRPPCTRDG | 151 | Q7RTU9 | |
| GSSCSPTPPPVPRRG | 236 | Q9NZQ3 | |
| GPSGGLRDPVTPTSP | 1771 | Q9Y566 | |
| GATLAPPTPPRPRDG | 471 | Q76KP1 | |
| AVDRSGVSLGPPPTP | 16 | Q7Z7M1 | |
| VPSALPNGPPSPRSG | 341 | Q15642 | |
| PNGPPSPRSGRDPLA | 346 | Q15642 | |
| GGVAPSAVPTRPPGP | 116 | Q9NRU3 | |
| PAPPPGRVSSIVAPG | 586 | Q9Y6X2 | |
| PPRAPRSSTPCPGGA | 406 | A6NDS4 | |
| PPRAPRSSTPCPGGA | 406 | P0C7X1 | |
| PGAGRQPPTPSAARP | 101 | Q5GH73 | |
| PELGTGSPARPPTPA | 206 | Q8IXK0 | |
| PPPAAPGSPGSLSLR | 521 | Q9H7S9 | |
| HSRSPSPEPRGRPGP | 291 | Q9UDY2 | |
| SPSHQARPGVPPPRG | 1261 | Q5TCY1 | |
| SVPTSRGVPPPPAIG | 121 | Q6ZSN1 | |
| PRPSGPGPSSFPRAS | 3026 | Q96T58 | |
| EGPGPRAAPVTVPTP | 26 | Q9NR83 | |
| PPRAPRSSTPCPGGA | 406 | A6NER0 | |
| ASPPPLAVPGTEGRP | 246 | Q8WVT3 | |
| SPPPSPRGEVERGPQ | 221 | Q12767 | |
| RAGTSPGGSPPARPI | 126 | Q8TEJ3 | |
| RLPNLSSPSAEGPPG | 456 | O60784 | |
| GPSAPGVDPSPPRRS | 41 | P0DUX1 | |
| GPSAPGVDPSPPRRS | 41 | A0A494C0Z2 | |
| GPSAPGVDPSPPRRS | 41 | P0DUD3 | |
| GPSAPGVDPSPPRRS | 41 | P0DUD4 | |
| GPSAPGVDPSPPRRS | 41 | P0DUD2 | |
| GPSAPGVDPSPPCRS | 51 | P0DV79 | |
| GPSAPGVDPSPPCRS | 51 | A0A494C086 | |
| GPSAPGVDPSPPCRS | 51 | Q495Y8 | |
| VSGPSAPGVDPSPPR | 31 | A6NKU9 | |
| GPSAPGVDPSPPCRS | 51 | A6NIY4 | |
| GPSAPGVDPSPPCRS | 51 | P0CI01 | |
| THPPGGTEPPRPRAG | 461 | Q8WWL2 | |
| PPIEGPPRPQRGSTS | 426 | Q8IV04 | |
| TTSEPGRGDKSPPPG | 191 | A6NLU5 | |
| HGSPRTRDPTPRPPG | 716 | Q96GP6 | |
| GTFPSTRPPGTPRAP | 46 | Q2MV58 | |
| TRPPGTPRAPGPSSG | 51 | Q2MV58 | |
| PSGRRTSPPPPGLAG | 191 | P26651 | |
| SPPSGAPGPPAGVRT | 301 | Q96DN2 | |
| PRGPESPRLAAGPSP | 371 | Q96DN2 | |
| GEPGASPRLSPGPST | 836 | Q96DN2 | |
| AVGPRSGFPPQPSLP | 316 | Q8N554 | |
| GAPAAPSPPPRGSRA | 16 | Q4KMP7 | |
| PSPPPRGSRAGPVVV | 21 | Q4KMP7 | |
| EEARPSPAPGPGTPT | 136 | Q4KMP7 | |
| SPAPGPGTPTGTPTR | 141 | Q4KMP7 | |
| PPVRRASAGPAPGPV | 681 | Q4KMP7 | |
| PPRAPRSSTPCPGGA | 406 | A0A087X179 | |
| TLSPAAGPASPEGPR | 1191 | Q86YV5 | |
| GSARRSAAVTGPPPP | 46 | Q99835 | |
| PPPGVASASARGPPA | 406 | Q9UFB7 | |
| GQGTRPSPTPVTPRP | 446 | Q6EMK4 | |
| GSPVSGVPEPGSPRS | 321 | Q6UWB4 | |
| GAATPAPTVRPGTPP | 296 | Q9NWS9 | |
| TPGKRGSPQTPPGRS | 86 | Q96JG9 | |
| EEPSGPRGPSSGHPL | 871 | Q96JG9 | |
| SPGPAPRVPRAVGPS | 16 | Q9H330 | |
| SRPAAPPAPGPGQLT | 66 | Q99536 | |
| GPPRPPGLCDDSPTS | 166 | Q8N398 | |
| SSPGPPETTARPTPG | 166 | Q96NZ8 | |
| DSTTPPAKSPRGGPG | 1091 | Q8N1G0 | |
| PGPRPSSGSHRSPAR | 656 | Q9ULC8 | |
| RSPARQGLPSPPGTP | 666 | Q9ULC8 | |
| GGPVSSPRAPRPVVS | 331 | O60346 | |
| PAVVSLPRPAGTPGP | 1091 | Q5SXM2 | |
| GPSAPGVDPSPPRRS | 41 | A0A494C191 | |
| GGPPTPTQPPCTRDG | 151 | A6NGW2 | |
| PRPSALRPTAGSGPD | 16 | Q9ULZ0 | |
| SDPRPGPGPPSVGSA | 126 | A6NIX2 | |
| PPRAPRSSTPCPGGA | 406 | A0A087WVF3 | |
| EPGPDSPGGSSPPRR | 1386 | Q92508 | |
| ESSGPPRPSRGPAAA | 6 | Q9UHD9 | |
| PPEGQAPPSHSPRGT | 1846 | Q12789 | |
| DSLPGSPSRGLGPPS | 81 | Q13425 | |
| PPRAPRSSTPCPGGA | 406 | Q6DHY5 | |
| PPRAPRSSTPCPGGA | 406 | Q8IZP1 | |
| SSQGPTVPPPPRGHA | 11 | Q8TC26 | |
| GSRHGSARPGPTPEP | 36 | Q8N6N2 | |
| SARPGPTPEPSGSLG | 41 | Q8N6N2 | |
| ARPSGLPAPAPGPTS | 101 | Q8N6N2 | |
| PGPTSSPGPARLSEE | 111 | Q8N6N2 | |
| PPRAPRSSTPCPGGA | 406 | A0A087X1G2 | |
| VGSPPSGSTPPQGPR | 756 | O75385 | |
| PGTPEPRPATPGASS | 6 | Q9H3U1 | |
| PGPGTPTGPSLPSKR | 576 | O15209 | |
| RGPPDSPDGSPLTPV | 1021 | Q63HR2 | |
| GARRPGPAASPTPGP | 21 | Q9NUE0 | |
| ASLEPGPPAPSRGRP | 111 | Q2T9J0 | |
| TPGRPSLGPALSTGP | 231 | O95231 | |
| PPRAPRSSTPCPGGA | 406 | A0A087WXS9 | |
| PPRAPRSSTPCPGGA | 406 | Q6IPX1 | |
| SPPLPSVSAGLGEPR | 51 | Q6ZNR0 | |
| PEGPLPSSSPRSPSG | 1441 | P49815 | |
| RGSATRALPPGPPTG | 321 | P49674 | |
| SSAPGGPPERTVTPA | 201 | Q9C0E8 | |
| SRPPTAVSSPGGPAR | 136 | Q9BWU0 |